289 yritystä löytyi.  = FIB jäsenyritys |
|---|
| Company | Contact information | Activities |
|---|
4Pharma Ltd
Lemminkäisenkatu 1, FI-20520 Turku, Finland
Web site: www.4pharma.com
Founded: 2002
Personnel: 15 (2004) | Marko Suojanen, Executive Vice President
Phone: +358 44 029 7796
Fax: +358 2 283 5701
marko.suojanen(at)4pharma.com Jari Turunen, Vice President, Technology
Phone: +358 44 029 7783
Fax: +358 2 283 5701
jari.turunen(at)4pharma.com | R&D activities: Local, world-class services in statistics, data management, data warehousing and medical writing. A wide variety of expertise in information technology, international regulatory affairs and pharmaceutical R&D overall. Categories of activity: Biotech support company; R&D service; Other service; |
AB Enzymes Oy
PO Box 26, FIN-05201 Rajamäki, Finland
Web site: www.abenzymes.com
Founded: 1997
Turnover: EUR 2,2 million (2004)
Personnel: 14 (2004) | Pentti Ojapalo, Textile Group Manager
Phone: +358 9 2902 2515
Fax: +358 9 2902 2550
pentti.ojapalo(at)abenzymes.fi | R&D activities: Development of technical enzyme applications. Core technologies: Technical enzymes for use in following industrial areas of application: detergent, textile, pulp and paper, animal feed. Categories of activity: Biotech company; Production; R&D; Enzymes; |
Abacus Diagnostica Oy Ltd
Tykistökatu 4 D, FI-20520 Turku, Finland
Web site: www.abacusdiagnostica.com
Founded: 2004 | Tom Palenius, Managing Director
Phone: +358 (0)20 7188 382
Fax: +358 (0)20 7188 381
tom.palenius(at)abacusdiagnostica.com | Production (and other) activities: Abacus Diagnostica Ltd is specialized in modern DNA testing technologies involving closed-tube detection of sensitive time-resolved fluorometric labels. The main product of Abacus Diagnostica is a proprietary, fully automated testing platform GenomEraTM that makes it possible to perform sophisticated DNA tests even outside a specialized laboratory environment. R&D activities: Rapid and simple DNA test systems for applications in medical and industrial diagnostics Core technologies: Closed-tube detection, Time-resolved fluorometry, GenomEra™ Tb and Eu labels, Competitive hybridization, End-point detection PCR
Categories of activity: Biotech company; Production; R&D; Supplier; Diagnostics and devices; Environment; Research reagents; |
Abcell Oy
PO Box 62, FI-33101 Tampere, Finland
Web site: www.abcell.fi
Founded: 1990 | Terho Eloranta, Managing Director
Phone:
Fax: +358 3 265 6213
abcell(at)kolumbus.fi | Production (and other) activities: Manufacturer of the unique AB-MAX Plasma Cell Growth supporters keeping antibody-producing B lymphocytes alive and rescuing dying hybridomas. Custom-tailored production of hybridoma cell lines, monoclonal and polyclonal antibodies, antisera and hen antibodies. Distributor services of IVD and research instruments, reagents and materials. Categories of activity: Biotech company; Production; Other service; Supplier; Diagnostics and devices; Research reagents; |
Aboatox Oy
Savikuja 2, FI-21250 MASKU, FINLAND
Web site: www.aboatox.com
Founded: 2001
Personnel: 1 (2009) | Juha Lappalainen, PhD, Managing Director
Phone: +358 2 2410 244
Fax: +358 2 2410 244
juha.lappalainen(at)aboatox.com | Production (and other) activities: Production of toxicitymonitoring tests based on photobacterium Vibrio fischeri and Genetically Engineered Heavy Metal Biotests. Sales of luminometers and chemicals for luminescence analysis (ATP, reporter gene). Hygiene monitoring kits and instruments. Microscale environmental toxicity tests based on maintenance free Microbiotests. R&D activities: Improved use and new applications of luminescent bacteria. Kinetic measurement with photobacteria. Core technologies: Luminometry. Categories of activity: Biotech company; Production; R&D; Food and feed; Environment; |
Afore Oy
| | Categories of activity: |
Agropolis Oy
| | Categories of activity: |
Ailab Solutions Oy
Eteläinen Makasiinikatu 4, FIN-00130 Helsinki, Finland
Web site: www.ailabsolutions.com
Founded: 2000
Personnel: 6 | Ari Aalto, CEO
Phone: +358 400 801166
Fax: +358 9 6852030
ari.aalto(at)ailabsolutions.com Dr Tommi Rakshit, Business Development
Phone: +358 40 585 6185
Fax: +358 9 685 2030
tommi.rakshit(at)ailabsolutions.com | Production (and other) activities: Our intelligent algorithms solve complex optimization, prediction and classification problems. They can handle hundreds of parameters and massive databases. The applications range from predicting molecule activity to modelling metabolic fluxes. R&D activities: We have more than ten joint R&D project with companies and university groups. The projects result new intelligent software tools for scientists and patentable scientific discoveries. Core technologies: All intelligent computational technologies including genetic algorithms, neural networks and support vector machines. Categories of activity: Biotech company; Bioinformatics; |
AKELA Pharma Inc.
| | Categories of activity: |
Akela Pharma Oy
PO Box 980, FIN-20101 Turku, Finland
Web site: www.labinc.fi
Personnel: 42 (2004) | Bastiaan J. de Leeuw, Vice President, Business Development and Strategy
Phone: +44 79 4135 6562
Fax: +358 2 333 3444
deleeuwb(at)akelapharma.com | Production (and other) activities: Production Rapid scaling-up of the manufacturing processes during the clinical phases of development.Production unit is part of 12,000 square metre facility. R&D activities: Expertise in carrier based dry powder formulation technologies including wet suspension technology with ultrasound processing produces highly homogeneous and physically stable powder formulations. Core technologies: LAB Pharma Oy offers an integrated product development partnership. Technology platform comprises patended powder formulations, approved TAIFUN inhaler and customised manufacturing technologies. Categories of activity: Biotech company; Production; R&D; Drug discovery; Diagnostics and devices; |
Algol Pharma Oy
Karapellontie 6, FI-02611 ESPOO, FINLAND
Web site: www.algolpharma.com
Founded: 1894
Turnover: EUR 46 million (2009)
Personnel: 120 (2009) | Jarmo Niiranen, Manager, Business Development, Sales and Marketing
Phone: +358408699332
Fax:
jarmo.niiranen(at)algol.fi | Production (and other) activities: We are looking for new co-operation partners with prescription (Rx) medicines. Sales and marketing co-operation in the Nordic and Baltic countries (7 -Country Concept). R&D activities: We are actively looking for long term co-operation partners with pharmaceutical original manufacturers globally. Our expertise areas are sales and marketing and all pharmaceutical services.
We would like to introduce our company and I hope we can arrange meeting with you if you are looking for high quality and trustworth business partner in Nordic and Baltic countries. This is a network of seven countries included. Core technologies: Our clients/partners are original manufacturers of Rx-pharmaceuticals from all over the world. Categories of activity: Biotech support company; Other service; |
Alimetrics Ltd
Web site: www.alimetrics.net
| | Categories of activity: |
Alkomohr Biotech Oy Ltd
Lehtotie 8, FIN-00630 Helsinki, Finland
Founded: 1995
Personnel: 3 | Dr Matti Korhola, Managing Director
Phone: +358 50 562 6903
Fax: +358 9 728 3937
matti.korhola(at)yeast.pp.fi | R&D activities: Research, product and process development on industrial enzymes and yeasts. Core technologies: Baker's, brewer's, distiller's, sour dough, and wine yeast strain improvement by classical genetic breeding and by genetic engineering. Proprietary enzyme application technology. Categories of activity: Biotech support company; Other service; Enzymes; |
Ani Biotech Oy
Tiilitie 3, FI-01720 Vantaa, Finland
Web site: aimo.niskanen@anibiotech.fi
Founded: 1987
Turnover: EUR 1,5 million (2009)
Personnel: 18 (2009) | Niskanen Aimo, CEO
Phone: 020 1557512
Fax: 020 1557517
| Production (and other) activities: Manufacturing lateral flow rapid tests for infectious diseases, cardiac markers, gastroenterology tests and fertility tests.
ELISA tests for infectious diseases, research kits for Interleucins (Orgenium business Unit)
R&D activities: Developing new applications for main activity areas.
Core technologies: Lateral Flow Technology, Multicannel technology and Dry dot agglutination technology, ELISA Categories of activity: Biotech company; Supplier; Diagnostics and devices; Research reagents; |
Ani Labsystems Oy Ltd
Tiilitie 3, FI-01720 Vantaa, Finland
Web site: www.anilabsystems.com
Founded: 2002
Turnover: EUR 3 million (2005)
Personnel: 28 (2005) | Ilari Tuominen, Marketing Manager
Phone: +358 40 518 6515
Fax: +358 20 155 7521
ilari.tuominen(at)anilabsystems.com Aimo Niskanen, Managing Director
Phone: +358 400 454 020
Fax: +358 20 155 7521
aimo.niskanen(at)anibiotech.fi | Production (and other) activities: Diagnostic EIA kits and reagents for use in clinical and research laboratories. Main areas of interest: infectious diseases, neonatal screening and OEM manufacturing. Latest product launches in 2009: Neonatal screening tests for G6PD, 17-OHP and Galactosemia R&D activities: New generation EIA kits for respiratory infections, other infectious diseases, gastrology problems, hormone detection, blood screening and neonatal screening. Core technologies: EIA, FEIA, MIF. Categories of activity: Biotech company; Production; R&D; R&D service; Other service; Supplier; Diagnostics and devices; Biomaterials; Research reagents; |
ArboNova Oy Ab
| | Categories of activity: |
ArcDia Group - Arctic Diagnostics Oy and ArcDia International Oy Ltd.
Tykistökatu 6, 20521 Turku, PL51
Web site: www.arcdia.com
Founded: 1993
Turnover: EUR 0,5 million (2009)
Personnel: 10 (2009) | Erkki Soini, CEO
Phone: +358-400-520643
Fax: 02-4544159
erkki.soini(at)arcdia.com | Production (and other) activities: technology R&D and licensing R&D activities: in vitro diagnostics Core technologies: Two photon fluorescence excitation "TPX" Categories of activity: Biotech company; Production; R&D; Diagnostics and devices; |
Ark Therapeutics Oy
Microkatu 1 S, FI-70210 Kuopio, Finland
Web site: www.arktherapeutics.com
Founded: 1993
Turnover: EUR 9 million (2008)
Personnel: 100 (2008) | Timo Ristola, Managing Director
Phone: +358 17 240 879
Fax: +358 17 240 876
timo.ristola(at)arktherapeutics.com Matti Lähde, Production Director
Phone: +358 17 240 873
Fax: +358 17 240 876
matti.lahde(at)arktherapeutics.com | Production (and other) activities: ARK offers proven expertise in the chemistry and manufacturing control (CMC) and development of biologicals, based on the common technical document (CTD) submission of Cerepro to EMEA in 2005/2008.
ARK has the approved/registered facilities and quality systems to meet IMPD and commercial needs within Europe, for terminally filtered live viral products meeting BSL2 requirements.
ARK has the capability to provide complete packages from research through development to commercial product fulfilling cGMP requirements R&D activities: ARK’s gene-based medicine research has provided numerous challenges to the GMP manufacturing development group, including analytical development and process validation.
Core technologies: ARK has GMP clean rooms and development suites to allow product and process development from adherent into suspension cell processes.
ARK will provide project documentation to meet GMP requirements for complete packages, and can offer full regulatory expertise in Europe and the USA
ARK is able to offer expertise in biologics manufacture - from proof of concept to commercial manufacture, to other organisations. These may range from university start-ups to major pharma needing specialist filling of live BSL2 type product. Categories of activity: Biotech company; Production; R&D; R&D service; Drug discovery; |
Aromtech Ltd
Veturitallintie 1, FIN-95410 Kiviranta/Tornio, Finland
Web site: www.aromtech.com
Founded: 1991
Turnover: EUR 2 million (2006)
Personnel: 13 (2006) | Dr Vesa-Pekka Judin, Managing Director
Phone: +358 40 742 9639
Fax: +358 207 789 029
vesa-pekka.judin(at)aromtech.com Mr Veli-Markku Korteniemi, Chairman of the Board
Phone: +358 400 392 494
Fax: +358 207 789 028
veli-markku.korteniemi(at)aromtech.com | Production (and other) activities: Marketing and manufacture of food supplements, as well as ingredients for cosmetics and functional foods R&D activities: Development of natural active ingredients for nutrition and cosmetics. Core technologies: Supercritical CO2 extraction
Sea buckthorn: abundance, chemistry, processing, clinical trials/physiological effects
Sourcing of highly functional natural ingredients of northern origin Categories of activity: Biotech support company; Production; R&D; Food and feed; |
Astra Zeneca Oy
| | Categories of activity: |
Atrotech Oy
| | Categories of activity: |
Auratum Group
| | Categories of activity: |
Avenly Oy
Pohjanpellontie 16 D, FI-00780 Helsinki, Finland
Web site: www.avenly.fi
Founded: 1998
Personnel: <1 (2006) | Hannu Salovaara, Chairman of Board
Phone: +358 400 417792
Fax:
hannu.salovaara(at)avenly.fi | Production (and other) activities: Avenly Oy (Ltd.) studies and develops traditional foods processes to meet todays needs.
The company has licensed out technology for an oat bran based alternative to dairy or soy yogurts.
A commercially successful product has been on the market in Finland for several years.
In the process, fermentation occurs, using probiotic bacteria. The substrate is high in functional oat beta-glucan. Both components, the probiotic bacteria and the soluble oat fibre provide health claim potential. Core technologies: Oat bran, fermentation. Categories of activity: Biotech support company; R&D; Other service; Food and feed; |
B.Braun Medical Oy
| | Categories of activity: |
Bayer Oy
Bayer CropScience
Suomalaistentie 7, FI-02270 Espoo, Finland
Web site: www.bayercropscience.com
Personnel: 1 | | Production (and other) activities: Markets crop protection products. Categories of activity: Biotech support company; Supplier; Agro; |
Bayer Schering Pharma Oy
PO Box 415, FIN-20101 Turku, Finland
Founded: 1946
Personnel: 965 | Hanna Räsänen, Technology Manager, Business Development
Phone: +358 2 333 2413
Fax: +358 2 333 2650
hanna.rasanen(at)bayer.fi | Production (and other) activities: Production Production of polymer based implants and IUS (intra uterine systems) and production of traditional pharmaceuticals. R&D activities: Develops polymer based drug delivery systems and polymers controlling the release rate. Categories of activity: Biotech company; Production; R&D; Drug discovery; |
BBS Bioactive Bone Substitutes Oy
| | Categories of activity: |
BCB Medical Ltd.
| | Categories of activity: |
BD Biosciences
| | Categories of activity: |
Berggren Oy Ab
| | Categories of activity: |
Bio Fund Management Oy Ltd
PO Box 164, FI-00101 Helsinki, Finland
Web site: www.biofund.fi
Founded: 1997
Personnel: 11 (2007) | Morten Bro Nielsen, Managing Partner
Phone: +45 2964 7727
Fax: +358 9 251 44 620
morten.bro.nielsen(at)biofund.dk | Production (and other) activities: Bio Fund Management Oy Ltd is one of the leading European venture capital management companies investing solely in life sciences. The main sectors include pharmaceuticals and therapies, medical technologies (medtech), cleantech and nutrition. BioFund's investment focus is exclusively on minority equity interests. BioFund makes investments solely in unlisted growth companies. In addition to early stage investments BioFund may also invest in expansion capital, turn-around and restructuring as well as MBO's and MBIs. BioFund is headquartered in Helsinki, Finland and maintains an office in Turku and in Copenhagen, Denmark. BioFund's ventures are concentrated in Europe, particularly in the Nordic countries. Categories of activity: Biotech support company; |
Bio-Rad Laboratories Inc.
| | Categories of activity: |
Biocelex Oy
Lemminkäisenkatu 5 C, FI-20520 Turku, Finland
Web site: www.biocelex.com
Founded: 2007
Turnover: EUR <1 M€ million (2008)
Personnel: 3 (2007) | Kai Lahtonen, President & CEO
Phone: +358 50 689 48
Fax: +358 2 4788 488
kai.lahtonen(at)biocelex.com | Production (and other) activities: Biocelex Ltd is a privately-held international innovation and business development company offering services for the Life Sciences field. We focus on business and technology areas related to drug discovery & development, diagnostics, biomaterials, functional foods and life science services. Geographically we operate in Scandinavia and the Baltic Sea region, with a particular focus on Finland.
In terms of Innovation Development, Biocelex adapts and applies the world famous and proven process of one of its co-owners, Karolinska Institutet Holding AB. We evaluate, consult and develop promising innovation to start-ups with a possibility for early-stage funding from Karolinska Development AB fund.
Biocelex Ltd offers Business Development services for a broad range of Life Science companies. For growth phase companies, our experienced team can help you with e.g. strategy and business planning, product development and market entry. For established companies looking for new openings or additions to their product portfolio, we offer e.g. scouting services, due diligence or technical assessments and reports on the local operating environment.
Categories of activity: Biotech support company; Other service; |
BioChance Oy
Laivurinrinne 2 A 6, FIN-00120 Helsinki, Finland
Founded: 1998 | Marja-Liisa Huhtala, Managing Director
Phone: +358 9 68427900 and
Fax: +358 9 6842 7901
marja-liisa.huhtala(at)kolumbus.fi | Production (and other) activities: Develops immunoassay technology and syntehtic peptide and recombinant antigens for infectious diseases serology. Categories of activity: Biotech company; R&D; Diagnostics and devices; |
BIOCID Oy Ltd
Teknobulevardi 3-5, PO Box 35, FI-01531 Vantaa
Web site: www.biocid.com
Founded: 2001
Turnover: EUR < 1 million
Personnel: 5 | | Production (and other) activities: Oy BIOCID Ltd - advanced food hygiene technologies that offer an integrated service concept for optimizing production hygiene and improving operational quality in any food industry enterprise. Core technologies: BIOCID is not a traditional company in the biotechnology (microbiology and hygiene management) or electronics (electronic equipment and process control) sector, but rather represents an innovative combination of the two.BIOCID carries out design and production of electronic UVC irradiators, integrates systems, and supplies activated oxygen generators as well as control measuring and sensor technology. Categories of activity: Biotech company; Production; Other service; Diagnostics and devices; Food and feed; |
BioCis Pharma Oy
Pharmacity, Itäinen Pitkäkatu 4B, FI-20520 Turku, Finland
Web site: www.biocis.com
Founded: 2003
Personnel: 5 (2009) | Dr Lasse Leino, CEO
Phone: +358 40 8494 694
Fax: +358 2 4788 371
lasse.leino(at)biocis.com Dr Jarmo Laihia, R&D Director
Phone: +358 2 478 8378
Fax: +3582 478 8371
jarmo.laihia(at)biocis.com | R&D activities: Development of new drugs for inflammatory and cancer diseases. Core technologies: Drug development, protodynamic therapy, cis-urocanic acid based therapeutics. Categories of activity: Biotech company; R&D; |
BioCity Turku
| | Categories of activity: |
Bioclin Oy
| | Categories of activity: |
Biocomputing Platforms Ltd
Tekniikantie 14, FI-02150 Espoo, Finland
Web site: www.bcplatforms.com
Founded: 1997 | Anita Eliasson, COO
Phone: +358 9 2517 7340
Fax: +358 10 296 1288
| Production (and other) activities: Marketing and development of data management solutions for genetic studies. Categories of activity: R&D service; Bioinformatics; |
Biodeus Oy
Lemminkäisenkatu 5C, FIN-20520 Turku, Finland
Web site: www.biodeus.com
Founded: 2000
Personnel: 5 | Jan Parkki
Phone: +358 400 536 835
Fax: +358 4 211 00 44
jan.parkki(at)biodeus.com | R&D activities: Biodeus develops new technology for protein purification. Categories of activity: Biotech company; R&D; |
Biofellows Oy
Koetilantie 1 C 18, FI-00790 Helsinki, Finland
Web site: www.biofellows.com
Founded: 1998
Turnover: EUR 2,5 million (2009)
Personnel: 8 (2009) | Mr Veli-Pekka Karvinen, Managing Director
Phone: +358 9 755 2550
Fax: +358 9 7552 5555
veli-pekka.karvinen(at)biofellows.com | Production (and other) activities: Distribution of molecular biology reagents and laboratory instruments. Categories of activity: Biotech support company; Supplier; Drug discovery; Diagnostics and devices; Enzymes; Research reagents; |
Bioferme Oy
Rauvolantie 64, FI-20760 Piispanristi, Finland
Web site: www.bioferme.fi
Founded: 1977
Turnover: EUR 2 million
Personnel: 11 | Merja Scharlin, Managing Director
Phone: + 358 2 276 2600
Fax: + 358 2 276 2621
merja.scharlin(at)bioferme.fi Reetta Myllymäki, Marketing Assistant
Phone: + 358 2 276 2600
Fax: + 358 2 276 2621
reetta.myllymaki(at)bioferme.fi | Production (and other) activities: Production Bioferme Oy manufactures Yosa and Yosa Plus oat products, fermented vegatable products and fruit/berry juices. Categories of activity: Biotech company; Production; Food and feed; |
Biofile Ltd
PO Box 450, FI-20101 Turku, Finland
Web site: www.biofilediagnostics.com
Founded: 1995 | Vesa Kleimola, CEO
Phone: + 358 2 481 81 00
Fax: + 358 2 481 81 01
vesa.kleimola(at)biofilediagnostics.com | Production (and other) activities: Biofile is a privately held Finnish company specialising in autoimmune disease and infectious disease diagnostics. The Company employs at the moment group of highly skilled and motivated professionals who develop and manufacture very sensitive and specific diagnostic test kits for gastroenterology autoimmune and infectious diseases. Biofile’s diagnostics products provide accuracy, simplicity and enable early disease diagnosis and treatment. All of Biofile's diagnostics products are used in procedures performed in vitro (outside the body) and enhance patient well being.
The current product portfolio of Biofile, based on well-known ELISA/IFA technologies, consists of a panel of six diagnostic kits for celiac disease, kit for helicobacter pylori testing and two kits for diagnosing Crohn's disease. Additionally the Company focuses also to the importing of certain autoimmune diagnostic kits to the Local market and surraounding markets, private labels some supporting diagnostic kits and runs a specialist clinical service laboratory. Clinical Laboratory helps the Company to keep in touch with customers and their needs today and in the future.
The Company has a strong background in research. Through its own personnel and scientific network Biofile has the technical expertise to enable research and product development efforts, in addition to celiac disease, in other autoimmune diseases as Crohn's disease, Colitis Ulcerosa and in infectious diseases as Helicobacter. Categories of activity: Biotech company; Production; Supplier; Diagnostics and devices; |
Biohit Oyj
Laippatie 1, FI-00880 Helsinki, Finland
Web site: www.biohit.com
Founded: 1988
Turnover: EUR 26,3 million (2003)
Personnel: 298 (2003) | Osmo Suovaniemi, President & CEO
Phone: +358 9 773 861
Fax: +358 9 773 86 205
osmo.suovaniemi(at)biohit.com | Production (and other) activities: Liquid handling: Electronic and mechanical pipettors, disposable pipettor tips, maintenance, calibration and training services. Diagnostics: Test panel (GastroPanel) for diagnosing Helicobacter pylori infection and atrophic gastritis as well as for screening the risk of gastric cancer, peptic ulcer, the reflux disease, and its complication, Barrett's oesophagus, from a blood sample. In addition, tests for the detection of lactose intolerance and systemic lupus erythematosus (SLE). Instruments: microplate readers, washers and related software, which support the performance and analysis of the results of the diagnostic tests. R&D activities: Liquid handling, diagnostics. Core technologies: Liquid handling, diagnostics, instruments, systems composed of the said product groups. Categories of activity: Biotech company; Production; Diagnostics and devices; |
Bioka Oy
Sokeritehtaantie 20, FI-02460 Kantvik, Finland
Web site: www.bioka.fi
Founded: 1992 | Paavo Lehtonen, Managing Director
Phone: +358 9 2230 2350
Fax: +358 9 2230 2350
paavo.lehtonen(at)kolumbus.fi | Production (and other) activities: Production Develops and manufactures enzyme based oxygen absorbers to be used in the packaging of food and pharmaceutical products. Core technologies: Oxygen absorbers Categories of activity: Biotech company; |
Biomarket Oy
Itäinen Pitkäkatu 4B, FI-20520 Turku, Finland
Web site: www.biomarket.fi
Founded: 2004
Personnel: 4 (2006) | Kari Kurki, Managing Director
Phone: +358 400 523 213
Fax: +358 2 478 8681
kari.kurki(at)biomarket.fi Arja Mannila, Margeting Manager
Phone: +358 50 3633 969
Fax: +358 2 478 8681
arja.mannila(at)biomarket.fi | Production (and other) activities: BioMarket Oy is a growing producer and distributor of diagnostic and molecular biology products for research groups, diagnostics industry and clinical laboratories.
BioMarket Oy offers more than 100 products in the field of infectious diseases, monoclonal antibodies, antigens,cardiac markers and CARD-i-KIT immunochromatographic IVD tests, extracellular matrix, integrin, endocrinology and molecular biology products including modifying enzymes and PCR. reagents. Categories of activity: Biotech company; Other service; Supplier; Diagnostics and devices; Enzymes; Research reagents; |
Biomedicum Genomics Oy
Haartmaninkatu 8, FI 00290 Helsinki, Finland
Web site: www.biomedicumgenomics.fi
Founded: 2007
Personnel: 5 (2008) | Dr. Outi Monni, Director
Phone: +358 40 763 9302
Fax:
outi.monni(at)helsinki.fi Anne Mäkelä, Project Manager
Phone: +358 9 191 256 31
Fax:
anne.makela(at)helsinki.fi | Production (and other) activities: BIOMEDICUM GENOMICS (BMGen) is a new functional genomics service provider operating at Biomedicum Helsinki. BMGen promotes nationwide biotechnology development by providing academic and industrial clients access to many functional genomics technologies and services. BMGen offers variety of biochip services for genome-wide expression, copy number profiling, miRNA expression, DNA-protein interaction (ChIP-on-chip) including e.g. RNA/DNA extraction and RNA quality assessment. For gene silencing and ectopic expression purposes, we offer high-titer shRNA or ORF lentiviruses targeting genes of interest. We also offer customized services e.g. preparation of gain or loss-of-function cell lines. In addition, we provide access to wide array of computational data analyses. BMGen also offers partnering deals for clients interested in customized integration of several technologies. Core technologies: Lentivirus mediated RNAi and biochip technologies. Categories of activity: Biotech company; Production; R&D; Other service; Biomaterials; |
Biomolecular Tools Finland Ltd.
| | Categories of activity: |
BioNavis Oy
Biokatu 6, FI-33520 Tampere, Finland
Web site: www.bionavis.com
Founded: 2006 | | Categories of activity: |
Bioprojects Consulting Services Ltd.
Vähäntorpankuja 7, FI-02180 Espoo
| Lauri Jalkanen, Director
Phone: +358-40-9030084
Fax:
laurijalkanen(at)dlc.fi | Production (and other) activities: Consulting services:
Business development of Life science fields. Assisting new (bio)technology based SMEs in focusing their strategies. Evaluation of new projects. Technology strategies. Market surveys. Business plans. Finding the necessary international business skills. Categories of activity: Other service; |
Bioretec Oy
Hermiankatu 22, Modulight Building, PO Box 135, FI-33721 Tampere, Finland
Web site: www.bioretec.com
Founded: 1998
Personnel: 29 (2009) | Pertti Viitanen, Chief Exectuive Officer
Phone: +358 20 778 9500
Fax: +358 3 317 0225
pertti viitanen(at)bioretec.com
Phone:
Fax:
| Production (and other) activities: Develops and manufactures new and innovative bioabsorbable devices for various fields of surgery in global markets. R&D activities: Development of novel bioabsorbable, bioactive or drug-releasing devices. Categories of activity: Biotech company; Production; R&D; Biomaterials; |
BioSilta Oy
PL 4300, 90014 Oulun yliopisto
Web site: www.biosilta.com
Founded: 2007
Personnel: 2009 (7) | Maria Ruottinen, Production manager
Phone: +358-44 557 1862
Fax:
maria.ruottinen(at)biosilta.com Russell Golson, CEO
Phone: 08-553 2361
Fax:
russell.golson(at)biosilta.com | Production (and other) activities: Production of fed-batch cultivation media for E.coli. EnBase is a time-saving cell cultivation kit available in micro- and deepwell plates and in shake flasks. R&D activities: Development of fed-batch cultivation media that will provide up to 50-times more bacteria and recombinant prteins/plasmid DNA than traditional cultivation methods.
Categories of activity: Biotech company; Biotech support company; Production; R&D; R&D service; Supplier; Diagnostics and devices; Research reagents; |
Biotech Job Partner Oy Ab
Kutomotie 16, 00380 HELSINKI Finland
Web site: www.biotechjobpartner.com
Founded: 2002
Turnover: EUR 0,1 million
Personnel: 1 | Anders Laurén, Managing Director
Phone:
Fax:
anders.lauren(at)biotechjobpartner.com | Production (and other) activities: Biotech Job Partner is a recruitment company. Our clients are leading biotechnology and pharmaceutical companies. Categories of activity: Biotech support company; Other service; |
BioTie Therapies Oyj
Tykistökatu 6, FI-20520 Turku, Finland
Web site: www.biotie.com
Founded: 1992
Turnover: EUR 1,118 million (2006)
Personnel: 40 (2006) | Kai Lähdesmäki, V.P. Business Development
Phone: +358 2 274 8941
Fax: +358 2 274 8910
kai.lahdesmaki(at)biotie.com Timo Veromaa, President & CEO
Phone: +358 2 2748 901
Fax: +358 2 274 8 910
timo.veromaa(at)biotie.com | Production (and other) activities: BioTie is a product development company developing proprietary pharmaceutical products with extensive IP.
Major partnering agreements have already been signed with global pharmaceutical companies like Roche, H. Lundbeck and other international companies.
R&D activities: BioTie R&D programs are developed from idea to end of Clinical Phase II (PoC).
When PoC is reached, the R&D programs are outlicensed to global and multinational pharmaceutical companies for extensive Clinical Phase III trials and international marketing.
Core technologies: The focus of BioTie R&D covers research and development for creating pharmaceutical products for the treatment of addiction disorders, autoimmune diseases and coagulation disorders. Categories of activity: Biotech company; R&D; Drug discovery; |
Biotop Oy
Tykistökatu 6 B 3, FIN-20520 Turku, Finland
Web site: www.biotop.fi
Founded: 1992
Turnover: EUR 1 million (2008)
Personnel: 4 (2008) | Risto Ranta, CEO
Phone: +358 2 241 0099
Fax: +358 2 241 0111
risto.ranta(at)biotop.fi | Production (and other) activities: Distribution of biodiagnostic kits and molecular biology products. R&D activities: Development of novel immunoassay kits. Categories of activity: Biotech company; Biotech support company; R&D service; Supplier; Diagnostics and devices; Research reagents; |
BioTurku / Turku Science Park Ltd
| | Categories of activity: |
Biovian Oy
| | Categories of activity: |
Bioxid Ltd
| | Categories of activity: |
Boneca Oy
| | Categories of activity: |
Boreal Plant Breeding Ltd
| | Categories of activity: |
Brion Scientific Ltd
| | Categories of activity: |
Carbozyme Ltd
Keilaranta 16, FI-02150 Espoo, Finland
Web site: www.carbozyme.fi
Founded: 1999 | Fred Fenel, Managing Director
Phone:
Fax:
fred.fenel(at)carbozyme.fi | R&D activities: Development and commercialization of products and methods of protein engineering. Categories of activity: Biotech company; R&D; R&D service; Enzymes; |
Cellogico Ltd.
| | Categories of activity: |
Cel´Amanzi Oy
Web site: www.celamanzi.com
| | Categories of activity: |
Centre for metrology and accreditation
FINAS
| | Categories of activity: |
Cerebricon Ltd.
Microkatu 1, FIN-70210 Kuopio, Finland
Web site: www.cerebricon.com
Personnel: 24 | Juha Yrjänheikki, CEO
Phone: +358 17 368 0801
Fax: +358 17 368 0803
juha.yrjanheikki(at)cerebricon.com Patrick Sweeney, Director of Business Development
Phone: +358 17 368 0801
Fax: +368 17 368 0803
patrick.sweeney(at)cerebricon.com | Production (and other) activities: Independent contract based research company providing specialized in vitro and in vivo brain disease models for testing and developing new pharmaceutical compounds for stroke, Alzheimer´s, Parkinson, Huntington, trauma, migraine etc. R&D activities: Development of models that are crucial for studying the efficiency of drugs, resolving the mechanisms action, searching new drug candidates for brain diseases, and screening for new drug targets. Fee-based services or shared R&D projects possible. Core technologies: Validated disease models with analysis methods ranging from molecular to functional and behavioral tests. Categories of activity: Biotech company; R&D; Drug discovery; |
Chempolis Oy
| | Categories of activity: |
Chip-Man Technologies Ltd
Web site: www.chipmantech.com
Founded: 2002
Personnel: 4 (2004) | Korpinen Juha, CEO
Phone: +358 3 3138 7046
Fax:
juha.korpinen(at)chipmantech.com | Production (and other) activities: Chip-Man Technologies produces living cell analysis systems, which don't need any labeling or markers, also the company produces cell-based-assays which are used in these systems. R&D activities: Machine Vision, machine learning, biology, cell models, cell based assays. Core technologies: Machine Vision, machine learning, biology, cell models, cell based assays. Categories of activity: Biotech support company; R&D service; Drug discovery; |
City-Lab Oy
Tykistökatu 6 floor 1, FI-20520 Turku, Finland
Web site: www.city-lab.fi
Founded: 1993
Personnel: 5 (2005) | Päivi Kemppainen
Phone: +358 2 469 1057
Fax: +358 2 469 1058
paivi.kemppainen(at)city-lab.fi | Production (and other) activities: We have three bioshops, one in Biocity, Turku and two others in Biomedicum and in Viikki, in Helsinki. In our shops you can shop or order reagents, consumables and small instruments from the companies we work with. Categories of activity: Biotech support company; Other service; Supplier; |
Clinical Research Institute Helsinki University Central Hospital Ltd
| | Categories of activity: |
Clinical Research Services Turku CRST
Itäinen Pitkäkatu 4 B, FIN-20520 Turku, Finland
Web site: www.crst.utu.fi
Founded: 1995
Turnover: EUR 1 million
Personnel: 23 (2009) | Anssi Himmanen
Phone: +358 2 333 7635
Fax: +358 2 333 7216
anssi.himmanen(at)utu.fi Mika Scheinin
Phone: +358 2 333 7502
Fax: +358 2 333 7216
mika.sheinin(at)utu.fi | Production (and other) activities: - Phase I, II and III clinical drug studies
- Clinical studies of medical devices
- Clinical studies of nutraceuticals and functional foods
- Study design and protocol writing
- Clinical Study reports
- Drug and biomarker assays from clinical and non-clinical samples
- Bioanalytics for REACH registration
- Toxicity studies and bioanalytics of eg. biocides Categories of activity: Biotech support company; R&D service; Other service; Drug discovery; Biomaterials; Food and feed; Environment; |
CNServices Oy
| | Categories of activity: |
ConMed Linvatec Biomaterials Oy
PO Box 3, FI-33721 Tampere, Finland
Web site: www.linvatec.com
Founded: 1984
Personnel: 60 (2005) | Kaj Koskinen, Managing Director
Phone: +358 3 316 5600
Fax: +358 3 316 5688
infofinland(at)linvatec.com | Production (and other) activities: ConMed Linvatec Biomaterials is the leading developer and manufacturer of procedure specific medicine products. R&D activities: Research and development of bioabsorbable surgical implants and instrumentation for procedure specific applications. R&D is based on high expertise and long experience of biomaterials and on comprehensively patent protected technologies. Core technologies: ConMed Linvatec Biomaterial's products are based on innovative material advantage, combined with worldwide patents and state of the art technologies. Categories of activity: Biotech company; Production; R&D; Biomaterials; |
Coronaria Feedback Oy
| | Categories of activity: |
Crown CRO Oy
| | Categories of activity: |
CRS Biotech Oy
Torikatu 8, FI-39200 Kyröskoski, Finland
Web site: www.crsbiotech.fi
Founded: 1995
Turnover: EUR 0,6 million (2007)
Personnel: 6 (2007) | Jari Siivari, Dr., Managing Director
Phone: +358400892386
Fax: +35833714330
jari.siivari(at)crsbiotech.fi | Production (and other) activities: Plant extracts for nutraceutical and cosmetic industry R&D activities: Agrobiotechnology, rural development projects including natural raw materials Core technologies: Dry extract production, vacuum drying, laboratory methods for biological samples (flavonoids, streols vitamins, etc.) Categories of activity: Biotech company; Production; R&D; Biomaterials; Food and feed; Agro; |
CRS-Research Ltd
| | Categories of activity: |
CRT (CleanRoom Tech)
VEHNÄMYLLYNKATU 6 33560 Tampere, Finland
Web site: www.crtoy.com
Founded: 1996
Turnover: EUR 1 million (2007)
Personnel: 5 (2007) | Pasi Kallio, MD
Phone: +358415035851
Fax: +35832540745
pasi.kallio(at)crtoy.com | Production (and other) activities: Cleanrooms, cleanroom devices and cleanroom products R&D activities: developing systems against harmful microbes Categories of activity: Biotech support company; Other service; Supplier; Environment; |
CSC Tieteellinen Laskenta Oy
| | Categories of activity: |
Culminatum Innovation Oy Ltd
Innopoli, Tekniikantie 12, 02150 Espoo
Web site: www.culminatum.fi
Founded: 1995
Personnel: 4 (2009) | Riikka Paasikivi, Program Director
Phone: +358-50-5215944
Fax: +358-10 2178901
riikka.paasikivi(at)culminatum.fi Laura Silvennoinen, Project Manager
Phone: +358-40-7048086
Fax: +358-10 2178901
laura.silvennoinen(at)culminatum.fi | Production (and other) activities: Culminatum Innovation Oy Ltd is a development company owned by the Uusimaa Regional Council, the cities of Helsinki, Espoo and Vantaa, and the universities, polytechnics, research institutes and business community of Helsinki region.
The main function of Culminatum Innovation Oy Ltd is to manage the Centre of Expertise Programme within Helsinki Region over the current third programme period 2007 - 2013. This programme promotes utilisation of the highest international standard of knowledge and expertise in business, job creation and regional development.
R&D activities: Over the years 2007-2013 the Centre of Expertise programme covers nine cluster fields in the Helsinki region:
> Digital Content Business
> Environmental Technology cluster
> Food Processing Development cluster
> HealthBio - Health cluster
> Living cluster
> Nano and Micro Systems and Future Materials, www.fmnt.net
> Tourism and Experience Industry
> Ubiquitous Computing
> Well-being cluster
Categories of activity: Other service; |
CyFlo Ltd
Itäinen Pitkäkatu 4 B, 20520 Turku, Finland
Web site: www.cyflo.fi
| Jussi Vaahtovuo, CEO
Phone: +358-2-4788520
Fax: +358-2-4788521
jussi.vaahtovuo(at)cyflo.fi | Production (and other) activities: CyFlo offers microbiological and immunological research and development services for food and feed industry, life sciences sector and other industries interested in microbes. Categories of activity: Biotech company; Biotech support company; R&D; R&D service; Other service; Diagnostics and devices; Food and feed; |
Cyncron Oy
Metsänneidonkuja 10, FI-02130 Espoo, Finland
Web site: www.cyncron.com
| Anja Forsberg, Country Manager
Phone: +358 9 7255 4405
Fax: +358 9 7255 4411
af(at)cyncron.com Benedikte Oestergaard, CEO Cyncron A/S
Phone: +45 42 14 62 15
Fax: +45 70 20 20 57
boe(at)cyncron.com | Production (and other) activities: Cyncron is a full service contract research organization. Our strength is our deep understanding and knowledge about the Nordic Region. We have offices in Denmark, Sweden and Finland. For clinical trial activities outside of our region we work through a formal partnership.
Cyncron will take your trial safely through all steps from feasibility to final report. We provide you with services on investigator selection, patient recruitment and site management. We also offer you expertise in biometrics, statistics, trial design and medical writing as well as regulatory activities and drug handling.
Cyncron offers you highly professional and committed staff for out-sourcing.
Try Cyncron, your reliable partner for clinical trials in the Nordic Region.
References as available upon request.
Categories of activity: Biotech support company; R&D service; Other service; |
Danisco Technology Center
Sokeritehtaantie 20, FIN-02460 Kantvik, Finland
Web site: www.danisco.com
Personnel: 97 | Nina Rautonen, Director, Bioscience
Phone:
Fax:
nina.rautonen(at)danisco.com Pekka Piiroinen, Development Director
Phone:
Fax:
pekka.piiroinen(at)danisco.com | Production (and other) activities: Production Food and feed ingredients, sweeteners and speciality carbohydrates. R&D activities: Gut microbiology and physiology and immunology, nutrition, gene technology, enzymology, fermentation, separation and process technology. Core technologies: Gene Technology, Separation Technology. Categories of activity: Biotech company; R&D; Agro; Enzymes; |
DelSiTech Ltd
Itäinen Pitkäkatu 4 D, FI-20520 Turku, Finland
Web site: www.delsitech.com
Founded: 2001 | Harry Jalonen, CEO
Phone: +358 2 4788 640
Fax: +358 2 4788 120
harry.jalonen(at)delsitech.com Gunnar Björkstén, Vice President Business Development
Phone: +358 2 4788 640
Fax: +358 2 4788 120
gunnar.bjorksten(at)delsitech.com | Production (and other) activities: DelSiTech Ltd specialises in a silica-based implant, subcutaneous and intra-muscular injectable technology for controlled release of small molecular drugs and biopharmaceuticals: proteins, polysaccharides (heparin) and viruses. Core technologies: DelSiTech(TM) is an advanced therapeutics delivery technology for implants, subcutaneous and intramuscular administration suitable for the controlled delivery of a wide range of active ingredients, including small molecules, proteins, heparin and viruses. The proprietary technology is based on silica (SiO2) matrix into which the active ingredient is embedded. The matrix can be designed to degrade at the required rate to assure a tightly controlled release of the active substance, providing a better therapeutic effect in situ and causing lower systemic toxicological side-effects than alternative delivery systems. The proof of principle has been demonstrated in animal testing both with small synthetic drugs and biologics like viruses. The technology was developed in two universities by the Biomaterial Research Group in Turku, Finland and is owned and patented by DelSiTech Ltd. Categories of activity: Biotech company; R&D; Diagnostics and devices; |
Dicode Oy
| | Categories of activity: |
Ekolab environmental Oy
| | Categories of activity: |
Elixi Oil Oy
| | Categories of activity: |
Elomatic Oy
Itäinen Rantakatu 72, FI-20810 Turku, Finland
Web site: www.elomatic.com
Founded: 1970
Turnover: EUR 38 million (2006)
Personnel: 600 (2006) | Aulis Rajala, Vice President
Phone: +358 2 412 4311
Fax: +358 2 412 4444
aulis.rajala(at)elomatic.com | R&D activities: Process development, Document management program, 3D-CAD solutions, CADMATIC. Core technologies: Consulting and engineering services from feasibility studies to validation and plant start-up for pharmaceutical and biotech investment projects. 3D-design using CADMATIC and CADMATIC eBrowser, Automation systems, Clean room design and Validation services. Categories of activity: Biotech support company; R&D service; |
Encorium Oy/Ltd.
Keilaranta 16, FI-02150 Espoo, Finland
Web site: www.encorium.com
Founded: 1996
Turnover: EUR 10 million
Personnel: 106 (2004) | Dr Kai Lindevall, CEO
Phone: +358 20 751 82 00
Fax: +358 20 751 8250
klindevall(at)encorium.com Hanna Kanerva, Senior Director, Country Manager
Phone: +358 20 751 8200
Fax: +358 20 751 8250
hkanerva(at)encorium.com | Production (and other) activities: Encorium is a Clinical Research Organisation (CRO) providing clinical research services to pharmaceutical, food and biotech companies. Encorium is a full service global CRO. Our areas of expertise are Cardiology and Cardiovascular diseases, Oncology, Immunology and Vaccines, CNS, and Endocrinology. Categories of activity: Biotech support company; Other service; |
EvoStem Finland Ltd.
Suntinmäentie 30, FI-36200 Kangasala, Finland
Founded: 2006 | Minna Leppänen, Managing Direcor
Phone: +358-40-504 4423
Fax:
minna.leppanen(at)evostem.com | Production (and other) activities: EvoStem develops, produces and markets stem cell therapies for veterinary use. Categories of activity: Biotech company; Production; R&D; |
Faron Pharmaceuticals Oy Ltd
Web site: www.faronpharmaceuticals.com
Founded: 2002
Turnover: EUR 0.16 million (2004)
Personnel: 1 (2004) | Markku Jalkanen, CEO
Phone: +358 40 520 6124
Fax: +358 2 478 8411
markku.jalkanen(at)faronpharmaceuticals.com | Production (and other) activities: Drug discovery and drug development services. R&D activities: Inflammation, Cancer, Traumas, Functional foods. Core technologies: Cell trafficking and adhesion (Clever, CD73, Vap-1, CD44v6), Biologically active GAGs, Farbetics, Tumobiotics. Categories of activity: Biotech company; Biotech support company; R&D; Other service; Drug discovery; Food and feed; |
FBD Oy Ltd
Web site: www.fatmanbiodesigns.com
Founded: 1999 | Prof. Mark S. Johnson, CEO
Phone: +358 40 505 9343
Fax: +358 2 215 3280
mark.johnson(at)fatmanbiodesigns.com | Production (and other) activities: FBD specializes in the computer-aided design of small molecule ligands on the basis of protein structural information and using bioinformational methods. Proprietary software is under development to help streamline the ligand design process. Core technologies: Protein modelling, x-ray crystallography, ligand design. Categories of activity: Biotech company; R&D service; Bioinformatics; |
Fennobon Oy
| | Categories of activity: |
Fennopharma Oy
| | Categories of activity: |
Fermion Oy
Koivu-Mankkaantie 6 A, FI-02101 ESPOO, Finland
Web site: www.fermion.fi
Founded: 1970
Turnover: EUR 65 million (2008)
Personnel: 310 (2008) | Hanspeter Ros, Vice President, CRAMS
Phone: 050 966 4004
Fax: 010 426 4424
hanspeter.ros(at)orion.fi | Production (and other) activities: Contract manufacturing of active pharmaceutical ingredients for the innovative and generic drugs industry R&D activities: Chemical synthesis, chiral compounds, scale-up Core technologies: cytotoxic agents, high-potent active pharmaceutical ingredients Categories of activity: Production; R&D; Drug discovery; |
Fermlab Oy
Lemminkäisenkatu 30, FI-20520, Turku, Finland
Web site: www.fermlabs.com
Founded: 2000
Personnel: 2 | Ari Båtsman, Managing Director
Phone: +358 2 2410012
Fax: +358 50 5731828
ari.batsman(at)fermlab.fi | Production (and other) activities: Manufacturing, sales and marketing of research reagents and probiotic bacteria. Subcontract manufacturing and services to diagnostic, biopharma and food industry and related research institutes. R&D activities: Research and development of probiotic bacteria applications. Core technologies: Research reagents: purification of CNS based proteins.
Probiotic bacteria: Functional effects, stability and other properties. Process optimization. Categories of activity: Biotech company; Biotech support company; Production; R&D service; Other service; Supplier; Drug discovery; Diagnostics and devices; Food and feed; Enzymes; Research reagents; |
Fibrogen Europe Oy
Tukholmankatu 8 A Biomedicum II, FI-00290 Helsinki, Finland
Web site: www.fibrogeneurope.com
Founded: 1995
Personnel: 2 (2009) | Dr Juha Koivurinta
Phone: +358 9 563 73 221
Fax: +358 9 563 73 224
jkoivurinta(at)fibrogeneurope.com | Production (and other) activities: Pilot production of different collagen types. R&D activities: Development of different collagen types, mainly types I, II, III and different collagen fragments (gelatins) for pharmaceutical and medical device use. Core technologies: Production of stable recombinant human collagens and gelatin using the patented multi-gene technology. Categories of activity: Biotech company; Supplier; Biomaterials; |
Finn-Medi Research Ltd
Finn-Medi Science and Business Park
Biokatu 12, FI-33529 Tampere, Finland
Web site: www.finnmediresearch.com
Founded: 1995
Turnover: EUR 2 million
Personnel: 14 | Matti Eskola, Managing Director
Phone: +358 3 3116 4020
Fax: +358 3 3116 4029
matti.eskola(at)finnmedi.fi Tiina Kärjä-Lahdensuu, Research Manager
Phone: + 358 3 3116 4034
Fax: + 358 3 3116 4029
tiina.karja-lahdensuu(at)finnmedi.fi | Production (and other) activities: Finn-Medi Research offers expertise and services for health and biotechnology companies, researchers and pharmaceutical industry. Customers represent from biotechnology start-ups up to major pharmaceutical companies. Services include clinical trials (phase I-IV), business development and licensing, R&D consulting and project management. Finn-Medi Research also coordinates biotechnology development programs such as BioneXt Tampere and Centre of expertise programme. Bionext Tampere is 100 milion investment and development programme that focuses on immunology and vaccines, biomaterials and tissue technology and applied information technologies. Categories of activity: Biotech support company; Biotech centre; R&D service; Other service; |
Finnfeeds Finland Ltd (trading as Danisco Animal Nutrition)
Sokeritehtaantie 20, FIN-02460 Kantvik, Finland
Web site: animalnutrition.danisco.com
Founded: 1998
Turnover: EUR 35 million
Personnel: 80 | Juhani O. Kuusisto, Managing Director
Phone: +358 10 4314686
Fax: +358 10 4314333
juhani.kuusisto(at)danisco.com | Production (and other) activities: Production Production facility in Naantali producing betaine and other molasses based fine chemicals. Core technologies: Cromatographic separation. Categories of activity: Biotech company; Production; Food and feed; Enzymes; |
Finnfeeds Ltd (trading as Danisco Animal Nutrition)
PO Box 461, FIN-65101 Vaasa, Finland
Web site: animalnutrition.danisco.com
Founded: 1991
Turnover: EUR 35 million
Personnel: 16 | Juhani O. Kuusisto, Managing Director
Phone: +358 10 4314686
Fax: +358 10 4314333
juhani.kuusisto(at)danisco.com Rainer Skinnar, Plant Manager
Phone: +358 10 4313508
Fax: +358 10 4313500
rainer.skinnar(at)danisco.com | Production (and other) activities: Production Production facility in Vaasa producing feed enzymes. Categories of activity: Biotech company; Production; Food and feed; Enzymes; |
Finnish Red Cross Blood Service
Kivihaantie 7, FIN-00310 Helsinki, Finland
Web site: www.veripalvelu.fi
Founded: 1947
Turnover: EUR 70 million (2005)
Personnel: 500 (2005) | Jukka Partanen, Research Director
Phone: +358 9 5801298
Fax: +358 9 5801429
jukka.partanen(at)veripalvelu.fi | Production (and other) activities: Blood and blood-related products; laboratory service for organ and stem cell transplantation; laboratory services related to haemostasis, coagulation and blood grouping. R&D activities: Stem cells; tissue banking; services for organ and stem cell transplantation. Core technologies: In R&D: Cell and molecular biology; genomics and genetics; Categories of activity: Biotech company; R&D; Other service; |
Finnish seed potato centre Ltd./Suomen siemenperunakeskus Oy
| | Categories of activity: |
Finnoflag Oy
PO Box 262, FIN-70110 Kuopio, Finland
Web site: www.finnoflag.com
Founded: 1993 | Elias Hakalehto, PhD
Phone: +358 500 574 289
Fax: +358 17 282 2838
finnoflag(at)co.inet.fi | Production (and other) activities: Production Microbe samplers and sample treatment devices, reagents, services. R&D activities: Tests for rapid microbe diagnostics, new innovative tools for microbiology. Core technologies: New microbe detection and sampling technologies, development of health promoting substances. Categories of activity: Biotech company; R&D; Diagnostics and devices; |
Finnvera Oy
| | Categories of activity: |
Finnzymes Oy
Keilaranta 16 A, FI-02150 Espoo, Finland
Web site: www.finnzymes.com
Founded: 1986
Personnel: 89 (2009) | Pekka Mattila, CEO
Phone: +358 9 2472 3010
Fax: +358 9 2472 3200
fz(at)finnzymes.fi | Production (and other) activities: Thermostable DNA polymerases, other enzymes for molecular biology, PCR instruments and consumables, PCR-based diagnostics. Core technologies: PCR, diagnostics. Categories of activity: Biotech company; Production; R&D; Supplier; Diagnostics and devices; Enzymes; |
FIT Biotech Oy
Biokatu 8, FI-33520 Tampere, Finland
Web site: www.fitbiotech.com
Founded: 1995
Personnel: 37 (2008) | Kalevi Reijonen, CEO & President
Phone: +358 33138 7000
Fax: +358 3 3138 7050
kalevi.reijonen(at)fitbiotech.com | Production (and other) activities: FIT Biotech Plc is an innovative medical biotechnology company engaged in the development and commercialization of its proprietary Gene Transport Unit (GTU®) technology and GTU product applications in DNA vaccination and immune therapy. The company's other areas of expertise are artificial immunogen, recombinant protein and antibody technologies, as well as GMP grade process development and production of DNA vaccines. In addition, the company has developed and launched test kits for the detection of natural latex allergens. FIT Biotech was established in 1995 and is located in Tampere, Finland, with operations also in Tartu, Estonia. R&D activities: Leveraging its GTU technology platform, FIT Biotech has built a strong product pipeline that comprises a therapeutic HIV vaccine, a preventive HIV vaccine, as well as vaccines for melanoma, diabetes and hepatitis C. FIT Biotech's HIV vaccine programs have already progressed to the Phase I/II stage. Core technologies: GTU technology: applicable to DNA vaccination as well as to immuno and gene therapies for the modulation of the immune system via antigens or cytokines for use in the treatment of infectious diseases, cancer and allergies. Categories of activity: Biotech company; Production; R&D; R&D service; Supplier; Drug discovery; Diagnostics and devices; |
Fluilogic Oy
Westendinkuja 25 B, FI-02160 Espoo, Finland
Web site: www.fluilogic.fi
Founded: 1978
Personnel: 1 | Ilkka Talvinen
Phone: +358 40 555 0294
Fax: +358 102 961 307
ilkka.talvinen(at)fluilogic.fi | Production (and other) activities: Production sale and markeitng of EMB-dispenser (electromagnetic actuator) modules and MAB-dispenser (mechanical actuator) modules R&D activities: Development of dispenser systems for dispense range of 50 nanoliters to 1000 microliters. Core technologies: EMB-technology, a Fluilogic patented dispenser technology. Categories of activity: Biotech support company; Production; R&D; Diagnostics and devices; |
Foodfiles Oy Ltd
Neulaniementie 2 L 6, FI-70210 Kuopio, Finland
Web site: www.foodfiles.com
Founded: 1998
Personnel: 10 (2004) | Dr Essi Sarkkinen, Managing and Research Director
Phone: +358 17 288 1261 and
Fax: +358 17 288 1269
essi.sarkkinen(at)foodfiles.com Ms Pirjo-Leena Kinanen-Nimmrichter, Administrative Manager
Phone: +358 17 288 1270 and
Fax: +358 17 288 1269
pirjo-leena.kinanen-nimmrichter(at)foodfiles.com | R&D activities: Clinical studies for food and pharmaceutical industry, regulatory affairs (food, food ingredients) for food industry, consultation in nutrition and health claims. Categories of activity: Biotech support company; R&D service; Food and feed; |
Foodwest Oy
| | Categories of activity: |
FRH Technology Partnership Oy Ltd
Neitsytpolku 2b A 15-16, FIN-00140 Helsinki, Finland
Founded: 2003
Personnel: 3 | Kai Falck, Senior Partner
Phone: +358 50 5233 683
Fax: +358 9 638 724
kai.falck(at)welho.com Päivi Ryöppy, Senior Partner
Phone: +358 50 536 5233
Fax: +358 9 638 724
paivi.ryoppy(at)welho.com | Production (and other) activities: Management consulting, creating international partnerships, business development services, analysis and studies on life science sector. Categories of activity: Biotech support company; R&D service; Other service; Drug discovery; Diagnostics and devices; Food and feed; Agro; Environment; |
Functional Foods Forum
| | Categories of activity: |
Galanthia
Web site: www.galanthia.com
| | Categories of activity: |
Galena Ltd
| | Categories of activity: |
Galilaeus Oy
Kairiskulmantie 10, PO Box 113, FI-20781 Kaarina, Finland
Web site: www.galilaeus.fi
Founded: 1994
Personnel: 27 (2005) | Kristiina Ylihonko, CEO
Phone: +358 2 274 1450
Fax: +358 2 273 1460
kristiina.ylihonko(at)galilaeus.fi | Production (and other) activities: Contract manufacturing of New Chemical Entities (NCE's) and small volume intermediates or on-market active ingredients. Galilaeus has GMP compliant fermentation facility for the manufacture of small molecule pharmaceuticals, also cytostatics.
Process development for small molecule fermentation including strain construction/improvement, optimisation of fermentation conditions, downstream development, scale-up. R&D activities: Development of highly efficient fermentation processes for technologically demanding active pharmacetical ingredients and NCE's. Core technologies: Control of biosynthetic pathways in microbes by genetic engineering. Natural products chemistry. Categories of activity: Biotech company; Biotech support company; Production; R&D; |
GE Healthcare Turku Imanet Oy
| | Categories of activity: |
Genano Oy Ltd
Kimmeltie 3, FI-02110 Espoo,Finland
Web site: www.genano.fi
Founded: 1999
Turnover: EUR 1,5 million (2008)
Personnel: 5 (2009) | Mikael Rentto, Managing Director
Phone: +35897743870
Fax:
mikael.rentto(at)genano.fi Klaus Nissinen, Vice Preseident
Phone: +35897743870
Fax:
klaus.nissinen(at)genano.fi | Production (and other) activities: Genano air cleaning units R&D activities: Developing own patented Genano technology Core technologies: Genano air cleaning technology can remove particles, microbes and volatile organic chemicals down to 0.001microns in size with up to 99.5% efficiency. We use our air cleaning systems in dental labs, hospitals, hotels and anywhere else people are suffering from poor indoor air quality.
Categories of activity: Biotech support company; Other service; Biomaterials; Environment; Enzymes; Research reagents; |
Genencor International Oy
PO Box 13, FIN-42301 Jämsänkoski, Finland
Web site: www.genencor.com
Founded: 1990
Turnover: EUR 62 million
Personnel: 200 | Jouni Viljanen
Phone: +358 14 7494 400
Fax: +358 14 7494 410
jviljanen(at)genencor.com Aino Mansikkamäki
Phone: +358 19 2804 300
Fax: +358 19 2804 307
amansikkamaki(at)genencor.com | Production (and other) activities: Production Industrial enzymes and industrial fermentations. Core technologies: Manufacturing of industrial enzymes. Categories of activity: Biotech company; Production; Enzymes; |
Genolyze Ltd
PO Box 140, FIN-20521 Turku, Finland
Web site: www.genolyze.com
Founded: 2003
Personnel: 7 | Marko Mäenpää, CEO
Phone: +358 50 4616530
Fax: +358 10 633 8189
marko.maenpaa(at)genolyze.com | Production (and other) activities: Genolyze is bioinformatics research Service Company specializes in enhancing research, development and production processes by applying Bio-IT know-how.
Company’s mission is to save researchers time and grow the value of measured data by revealing the useful information hidden into the massive data and complex multivariable studies.
R&D activities: Computational methods for biological data, Biomarkers, Biological data management Core technologies: Sophisticated data analysis and computational methods, Mathematical and statistical modelling, Data management, IT and Bio-database systems. Categories of activity: Biotech company; Biotech support company; R&D service; Other service; Bioinformatics; |
GenoSyst Ltd.
Itäinen Pitkäkatu 4B, FI-20520 Turku, Finland
Web site: www.genosyst.com
Founded: 2006
Personnel: 7 (2007) | Robert Hermann, CEO
Phone: +358 2 478 8360
Fax: + 358 2 478 8120
robert.hermann(at)genosyst.com Attila Gyenesei, Director of Research and Development
Phone: +358 2 478 8360
Fax: + 358 2 478 8120
attila.gyenesei(at)genosyst.com | Production (and other) activities: GenoSyst Ltd. offers software and data analysis services for various domains of biosciences and bioindustry, with special focus on systems biology applications: transcriptomics - global gene expression profiling, genomics - disease gene mapping, proteomics and metabolomics. Additionally we provide in silico tools for drug discovery. R&D activities: GenoSyst Ltd. carries out research and development in the following areas: novel data mining techniques for whole genome association scans, whole genome sequence patterns discovery, global expression profiling, in silico HTS drug discovery - QSAR, maximal common substructures. Core technologies: Applications of advanced mathematics to uncover hidden knowledge in large scale biological datasets, advanced statistics, data mining. Categories of activity: Biotech company; Production; R&D; Other service; Bioinformatics; |
Genxpres Ltd
| | Categories of activity: |
Glykos Finland Oy
| | Categories of activity: |
H. Lundbeck Oy Ab
| | Categories of activity: |
HaartBio Oy Ab
Haartmaninkatu 3, FI-00290 Helsinki, Finland
Web site: www.haartbio.fi
Founded: 2003 | Marja-Liisa Lokki, Managing Director
Phone:
Fax:
| Production (and other) activities: Operates between university and biotechnological and medical companies marketing academic know-how and products. Categories of activity: Biotech support company; Other service; |
Headman Ltd
Porttitie 11 D, FIN-02180 Espoo, Finland
Web site: www.headman.fi
Founded: 1992
Personnel: < 10 | Klaus Hedman, MD, Professor
Phone: +358 50 5249 086
Fax:
klaus.hedman(at)helsinki.fi | Production (and other) activities: Diagnostics for infectious diseases. R&D activities: Diagnostics for infectious diseases; outsourced R&D; diagnostic consultation. Core technologies: IgG-avidity and epitope-type specificity serodiagnostics; other innovative antibody-EIA techniques; recombinant protein expression; molecular biology; quantitative PCR. Categories of activity: Biotech company; R&D; Diagnostics and devices; |
Helsinki Business and Science Park Ltd
Viikinkaari 4, FI-00790 Helsinki, Finland
Web site: www.hbsp.net
Founded: 1992
Turnover: EUR 2,8 million
Personnel: 15 (2008) | Pia Westerling
Phone:
Fax:
Antti Sekki, Business Development Director
Phone: +358 9 319 36 543
Fax: +358 9 319 36 554
antti.sekki(at)hbsp.net | Production (and other) activities: Helsinki Business and Science Park (HBSP) provides a dynamic business environment with a diversified research and expert network and a Centre of Expertise within food technology, biotechnology, drug development and diagnostics, as well as environmental technology. HBSP operates in two campuses within the City of Helsinki, in Viikki Biocampus and in Meilahti Medical Campus. Categories of activity: Biotech centre; Other service; |
Hermo Pharma Oy
| | Categories of activity: |
Hi-Col Ltd
| | Categories of activity: |
Hidex Oy
| | Categories of activity: |
Histola Research Oy
Niittyhaankatu 20, FI-33720 Tampere
Web site: www.histola.com
Founded: 2004
Personnel: 10 (2008) | Pia Kivijärvi, Managing Director
Phone: +358 20 7432 007
Fax: +358 20 7432 001
pia.kivijarvi(at)histola.fi Katja Veneskoski, Laboratory Manager
Phone: +358 20 7432 002
Fax: +358 20 7432 001
katja.vaneskoski(at)histola.fi | Production (and other) activities: Histola Research Ltd is a contract research organization that offers testing and tailored experts services for non-clinical operations. Histola is having GLP accredited laboratory premises. Our services covers from research planning to practical arrangements and project management. We are committed to long term high quality co-operation and cost-efficient expertise in the implementation of non-clinical operations.
• IN VITRO TOXICOLOGY AND CELL BIOLOGICAL RESEARCH
• HISTOTECHNOLOGY (Immunohistochemistry)
• ENVIRONMENTAL RESEARCH, ECOTOXICITY TESTING AND CONSULTANCY
• NANOSAFETY
• CHEMICAL TESTING (REACH) AND CONSULTANCY
• PROJECT MANAGEMENT SERVICES AND CONSULTANCY
Categories of activity: Biotech support company; R&D; R&D service; Other service; Supplier; Drug discovery; Diagnostics and devices; Biomaterials; Bioinformatics; Environment; |
Hormos Medical Corp. - a subsidiary of QuatRx Pharmaceuticals Company
USA
Itäinen Pitkäkatu 4, FIN-20520 Turku, Finland
Web site: www.hormos-med.com
Founded: 1997
Turnover: EUR 2 million (2004)
Personnel: 38 (2004) | Dr Risto Lammintausta, CEO
Phone: +358 2 410 8000
Fax: +358 2 410 8001
risto.lammintausta(at)hormos-med.com | Production (and other) activities: QuatRx Pharmaceuticals Company, a biopharmaceutical company, focuses on research and development of therapeutic compounds primarily for the treatment of major endocrine, metabolic and cardiovascular diseases, especially dyslipidemia and endocrine diseases of aging. QuatRx has its headquarters in Ann Arbor, Michigan, with a significant presence in Europe through Hormos Medical Corp., a wholly-owned subsidiary of QuatRx Pharmaceuticals Company. R&D activities: The research activities of the company are based on its expertise in tissue-specific steroid hormone effects at the molecular and cellular level. Currently running projects in the indication areas of menopausal symptoms, androgen deficiency disorders, dyslipidemia. Core technologies: The company's core technologies include selective estrogen receptor modulators (SERM), selective androgen receptor modulators (SARM) and hydroxysteroid dehydrogenase (HSD) inhibitors. Categories of activity: Biotech company; R&D; Drug discovery; |
Hycail Finland Oy
Tykistökatu 4D, FI-20520 Turku, Finland
Web site: www.hycail.fi
Founded: 2004
Turnover: EUR 0,5 million (2008)
Personnel: 3 (2009) | Svante Wahlbeck, Managing Director
Phone: +358-400 828326
Fax:
svante.wahlbeck(at)hycail.fi | Production (and other) activities: Biopolymer analytical services and R&D services R&D activities: Biomaterials product development Core technologies: PLA (lactic-acid based polymers) Categories of activity: Biotech company; Biotech support company; R&D; R&D service; Biomaterials; |
Hytest Ltd.
PharmaCity, Itäinen Pitkäkatu 4C, FI-20520 Turku, Finland
Web site: www.hytest.fi
Founded: 1994
Turnover: EUR 3,2 million (2003)
Personnel: 24 (2003) | Jukka Lehikoinen
Phone: +358 2 512 0900
Fax: +358 2 512 0909
jukka.lehikoinen(at)hytest.fi Susanna Brink
Phone: +358 2 512 0900
Fax: +358 2 512 0909
susanna.brink(at)hytest.fi | R&D activities: HyTest is continuously working to bring new products to the market as well as improving the existing ones through R&D. Our R&D specialists maintain close ties with the scientific community and engage in joint research with the Finnish academic diagnostic research organizations. Core technologies: HyTest has become a leading supplier of several reagents worldwide (such as antibodies and antigens of the troponin complex or native human thyroid peroxidase), at the same time maintaining a broad range of other products. Categories of activity: Biotech company; Production; R&D; Diagnostics and devices; |
Imanext Oy/Ltd.
Aleksanterinkatu 17, FI-00100 Helsinki, Finland
Web site: www.imanext.com
Founded: 2006 | Kim Bergström, CEO
Phone: +358 40 415 5741
Fax: +358 10 296 0313
kim.bergstrom(at)imanext.com | Production (and other) activities: Imanext Ltd. provides molecular imaging applications for drug development to the pharmaceutical and biotechnology industry. Imanext is a niche CRO (Contract Research Organization), and is operating in the field of translational imaging. Imanext’s services include nonclinical proof-of-concept studies using a wide spectrum of SPECT/PET (Single Photon Emission Computed Tomography / Positron Emission Tomography) tracers, and clinical phase I/II SPECT (including phase 0 and microdosing) studies. Imanext operates with its partners globally. Categories of activity: Biotech support company; Other service; |
Immuno Diagnostic Oy
Kaivokatu 16, FI-13100 Hämeenlinna, Finland
Web site: www.immunodiagnostic.fi
Founded: 1983
Turnover: EUR 4,0 million (2008)
Personnel: 10 (2008) | Dr Marko Laine, Vice President, Sales Director
Phone: +358 3 6153 725
Fax: +358 3 6822 039
marko.laine(at)immunodiagnostic.fi Mr Jarmo Laakkonen, Vice President, CEO
Phone: +358 3 6153 726
Fax: +358 3 6822 039
jarmo.laakkonen(at)immunodiagnostic.fi | Production (and other) activities: Marketing of kits for ultra-rapid immunohistochemical staining on frozen sections. Distribution of reagents, chemicals and instruments for research and diagnostic applications.ISO9001:2000 certificate. R&D activities: Technology transfer, commercialization and consulting. Categories of activity: Biotech company; Biotech support company; Production; R&D service; Supplier; Drug discovery; Diagnostics and devices; Biomaterials; Food and feed; Agro; Environment; Enzymes; Research reagents; |
info@bnpands.com
| | Categories of activity: |
Inion Oy
Lääkärinkatu 2, FI-33520 Tampere, Finland
Web site: www.inion.com
Founded: 1999
Personnel: 95 (2004) | Chris Lee, CEO
Phone: +44 (0) 1483 685 390
Fax:
chris.lee(at)inion.com Julien Cotta, CFO
Phone: +44 (0) 1483 685 390
Fax:
julien.cotta(at)inion.com | Production (and other) activities: Inion is dedicated to developing and manufacturing novel medical devises based on innovative biomaterials. Inion developed solutions feature a range of proprietary technologies and processes that offer significant benefits over alternative methods and have won a growing number of the customers around the world. Priority is given to solutions that can be used quickly and easily, save valuable OR time and are priced competitively. Inion's product range includes biodegradable products for the following surgical applications: Craniomaxillofacial (Inion CPS), Orthopaedics (Inion OTPS), Sports medicine (Hexalon, Trinion) and dental (Inion GTR membrane). R&D activities: Inion's material and product testing is carried out at the company's special R&D laboratory at the headquarters, equipped with state-of-the-art manufacturing, laboratory and office facilities as well as class 10 000 clean room. Materials analysis work is also carried here, and at the reasearch centres and universities around the world. Core technologies: Polymer science and processing technology are the core technologies of Inion. Categories of activity: Biotech company; Production; R&D; Biomaterials; |
Injectobone Finland Oy
| | Categories of activity: |
Innofinance Oy
| | Categories of activity: |
Innokas Medical Oy
| | Categories of activity: |
Innomedica Oy
Tykistökatu 6 B (BioCity), FI-20520 Turku, Finland
Helsinki office: Tukholmankatu 8 B FIN-00290 Helsinki, Finland
Web site: www.innomedica.fi
Founded: 1997 | Michael T Jones
Phone: +358 2 2748 400
Fax: +358 2 2748 420
innomedica(at)innomedica.fi Tanja Dowe
Phone: +358 400 636 107
Fax: +358 9 563 73209
innomedica(at)innomedica.fi | Production (and other) activities: Innomedica is a service provider for the Life Science industry. Our main service products are: Japan Partnering, Project Management Services, Business Development, Internationalisation. Using our experienced team of Life Science Professionals, we can help our clients to get the best our of their technologies and product ideas. Innomedica is your Partner in Life Sciences. Categories of activity: Biotech support company; Other service; |
Innotrac Diagnostics Oy
Biolinja 12, FI-20720 Turku, Finland
Web site: www.innotrac.fi
Founded: 1995
Personnel: 45 | Hannamaija Fontell, Marketing Director
Phone: +358 2 278 4000
Fax: +358 2 278 4001
| Production (and other) activities: Production and marketing of the Innotrac Aio!TM Immunoassay systems and reagents for cardiac and critical care testing in emergency environments. Contract manufacturing services in streptavidin coated plate and diagnostic reagent production for diagnostics, pharmaceutical companies and research institutions. R&D activities: Development of rapid, quantitative immunoassay systems and reagents for point-of-care and central laboratory testing. Core technologies: All-in-one dry chemistry technology and non-enhancement time-resolved fluorometry (TRF). Categories of activity: Biotech company; Production; R&D; R&D service; Other service; Supplier; Diagnostics and devices; |
Institute for Molecular Medicine Finland
FIMM
| | Categories of activity: |
Institute of Biotechnology Core Facilities and Service Units
P.O.Box 56 (Viikinkaari 9), FI-00014 University of Helsinki, Finland
Web site: http://www.biocenter.helsinki.fi/bi/
| | Production (and other) activities: The Institute of Biotechnology is an administratively independent unit of the University of Helsinki. The mission of the Institute is to promote high-level research and education in biotechnology, molecular biology, cell biology, and related areas. The Institute has the-state-of-the-art facilities in its R&D units, which offer services to researchers at the University as well as in industry. Categories of activity: R&D; R&D service; |
Inveni Capital Oy
| | Categories of activity: |
Invenire Market Intelligence Oy
Kokkilantie 835, FI-25230 Angelniemi, Finland
Web site: www.invenire.fi
Founded: 2003 | Patricia Wiklund, Managing Director
Phone: +358 (0)40 8228848
Fax:
patricia.wiklund(at)invenire.fi | Production (and other) activities: Invenire provides commercialisation support and market research. We have a professional and entrepreneurial team working internationally in the business of food and nutrition. Categories of activity: Biotech support company; Other service; Biomaterials; Food and feed; Agro; |
IP Finland Oy
| | Categories of activity: |
Ipsat Therapies Oy
Viikinkaari 4, FI-00790 Helsinki, Finland
Web site: www.ipsat-ther.com
Founded: 1999
Personnel: 30 | | Core technologies: A drug development company focusing on antibiotic-induced bacterial resistance, hospital infections, antibiotic-indiced colitis and diarrhea. Categories of activity: Biotech company; R&D; Drug discovery; |
JFP Executive Search Oy
| | Categories of activity: |
Jurilab Oy Ltd
Microkatu 1, FI-70210 Kuopio, Finland
Web site: www.jurilab.com
Founded: 1999
Personnel: 35 | Jukka T. Salonen, CSO
Phone: +358 207 219 200
Fax: +358 207 219 201
info(at)jurilab.com | R&D activities: Discovery and validation of gene-disease associations for therapeutic, diagnostic and nutritional applications. Core technologies: A proprietary method of identifying and verifying DNA variations, known as Hierarchical Phenotype-Targeted Sequencing (HPTS), and linking these mutations to diseases. Categories of activity: Biotech company; R&D service; Drug discovery; Diagnostics and devices; |
JVS-Polymers Inc
Innopoli, Tekniikantie 12, FI-02150 Espoo, Finland
Founded: 1994 | Dr Jukka Seppälä, Chairman of the Board
Phone: +358 9 251 73 430
Fax:
jvs(at)innopoli.fi | R&D activities: - Polymer technology and engineering
- Biopolymers technologies Core technologies: - Biodegradable polymer technologies
- Biomedical polymers Categories of activity: Biotech company; R&D; Biomaterials; |
Jyväskylä Innovation Oy
Piippukatu 11, 40100 Jyväskylä
Web site: www.jklinnovation.fi
Founded: 2006 | Veli-Pekka Heikkinen, Managing Director
Phone: +358 40 5399 214
Fax:
veli-pekka.heikkinen(at)jklinnovation.fi | Categories of activity: Biotech company; Biotech support company; Biotech centre; Other service; Biomaterials; Bioinformatics; Environment; |
Kaivogen Oy
Tykistökatu 4D, FI-20520 Turku, Finland
Web site: www.kaivogen.com
Founded: 2007
Turnover: EUR 0,6 million (2008)
Personnel: 7 (2009) | Leena Kokko, Managing Director
Phone: +358 50 5900853
Fax:
leena.kokko(at)kaivogen.com | Production (and other) activities: Production of protein coated microtiter plates (main product streptavidin coated plates)
Customised reagent production Categories of activity: Biotech company; Production; Research reagents; |
Kibron Inc.
Upseerinkatu 3 A, 02600 Espoo, Finland
Web site: www.kibron.com
Founded: 1994 | Jukka Kilpiö, Managing Director
Phone: +358 9 6811 920
Fax: +358 9 6811 9222
info(at)kibron.com Jana Nyrén, Marketing Director
Phone: +358 9 6811 920
Fax: +358 9 6811 9222
info(at)kibron.com | Production (and other) activities: Kibron develops and manufacturers analyzers and assays for the pharmaceutical and chemical industries as well as academic surface chemistry research. Categories of activity: Biotech company; Production; R&D; Drug discovery; Diagnostics and devices; Environment; Research reagents; |
kirsi.varmo@hus.fi
| | Categories of activity: |
Kojair Tech Oy
| | Categories of activity: |
Kolster Oy Ab
Iso Roobertinkatu 23, FI-00121 Helsinki
Web site: www.kolster.com
Founded: 1874
Turnover: EUR million
Personnel: 185 (2008) | Monica Lax, Branch Manager, Biotechnology and Chemistry
Phone: +358 9 618 821
Fax: +358 9 602 244
monica.lax(at)kolster.fi | Production (and other) activities: The mission of Kolster is to protect and manage our customers' intellectual property and support the development of industrial property rights. Our company has highly experienced resources in IP prosecution, especially in patenting in high-technology fields such as biotechnology and ICT. Our biotech team consists of 12 experts in biotechnology, genetics and chemistry. This team has gathered a great deal of experience in protecting biotechnology applications, most recently in the use of stem cells in diagnostics, micro arrays in cancer therapy and diagnostics, and probiotics in the food industry. Categories of activity: Biotech support company; Other service; |
Konstrumed Oy
| | Categories of activity: |
Kuomed Oy
| | Categories of activity: |
Kuopio Innovation Ltd.
PO Box 1188, Microkatu 1, FIN-70211 Kuopio, Finland
Web site: www.kuopioinnovation.fi
Founded: 2008
Turnover: EUR 2,3 million (2008)
Personnel: 20 | Heikki Nuutinen, Managing Director
Phone: +358 500 674 413
Fax: +358 17 441 2011
heikki.nuutinen(at)kuopio.fi | Production (and other) activities: Kuopio Innovation Ltd. helps local technology enterprises develop domestic and international business activity. It promotes cooperation between business and research aiming to the creation of new business activities. The focus of operation is in the fields of health, environment and wellbeing. The core of the operation is the Centre of Expertise Programme and its related development projects. More information: www.kuopioinnovation.fi. Categories of activity: Biotech support company; Biotech centre; R&D service; |
Labmaster Oy
Fiskarsinkatu 11, FI-20750 Turku, Finland
Web site: www.labmaster.fi
Founded: 1986
Personnel: 9 | Teppo Laaksonen, Managing Director
Phone: +358 2 276 0556
Fax: +358 2 276 0550
teppo.laaksonen(at)labmaster.fi | Production (and other) activities: Development, manufacturing and marketing of immunodiagnostic kits and reagents for applications in functional food research (metabolic end products of lignans and isoflavonoids) and routine clinical diagnostics (coeliac disease, osteoporosis, cardiac diseases). R&D activities: Labmaster Oy is developing new technology for clinical, biochemical and chemical analysis like also PCR analysis based on cathodic electrochemiluminescence (ECL) and application of microelectronics. Core technologies: Time-resolved fluoroimmunoassay, ELISA, cathodic electrochemiluminescence, microfabrication of silicon. Categories of activity: Biotech company; Production; R&D; Diagnostics and devices; |
Laborexin Oy
Holkkitie 14, PO Box 224, FI-00811 Helsinki, Finland
Web site: www.laborexin.fi
Founded: 1980
Turnover: EUR 0.6 million (2008)
Personnel: 6 (2008) | Pentti Tanskanen, Managing Director
Phone: +358 9 780 633
Fax: +358 9 781 393
pentti.tanskanen(at)laborexin.fi Timi Tanskanen, Product Manager
Phone: +358 9 780 633
Fax: +358 9 781 393
timi.tanskanen(at)laborexin.fi | Production (and other) activities: The company is specializing in manufacturing and marketing first class laboratory technology and glassblowing products. In addition, we represent numerous international laboratoryglass, equipment and biotechnology companies. R&D activities: Our goal is to cocentrate in technology transfer, where innovations in the academic research are developed to put them in the practice. Core technologies: Laboratory glassblowing, equipments, DNA Electrophoresis Kits, Protein Assays, Liphophilic Ionsensitive Electrodes. Categories of activity: Biotech support company; Production; R&D service; Supplier; Diagnostics and devices; Environment; Research reagents; |
leena.eskola@atostek.com
| | Categories of activity: |
Licentia Ltd
Tukholmankatu 8 A, FI-00290 Helsinki, Finland
Web site: www.licentia.fi
Founded: 2001
Turnover: EUR 1,5 million (2004)
Personnel: 7 | | Production (and other) activities: Commercialization of research results and technologies (.Technology transfer). Technology and IP consulting. Categories of activity: Biotech support company; Other service; Drug discovery; Diagnostics and devices; Bioinformatics; Food and feed; Research reagents; |
Life-Science-Man Oy Ltd
Keilaranta 16, FI-02150 Espoo, Finland
Web site: www.lifescience.fi
Founded: 2002
Personnel: 5 (2004) | Anu Harkki,, Managing Director, PhD, MBA
Phone: +358 9 8133 800
Fax: +358 9 8133 828
harkki(at)lifescience.fi Anu Mehtonen, Head of Regulatory Affairs, MSc
Phone: +358 9 8133 801
Fax: +358 9 8133 828
mehtonen(at)lifescience.fi | Production (and other) activities: Business and regulatory services for life science and chemical industries. - Management consulting services - Food regulatory affairs services - Chemical registration services (REACH Management) - Clinical studies and contract research services Categories of activity: Biotech support company; R&D service; Other service; Bioinformatics; Food and feed; Agro; Environment; |
Lightlake Sinclair Ltd.
| | Categories of activity: |
LP Research Centre Ltd
| | Categories of activity: |
Macrocrystal Oy
Ruukintie 20 F, FI-02320 Espoo, Finland
Web site: www.macrocrystal.com
Founded: 1993
Personnel: 4 | | Production (and other) activities: Crystallization process development by contracts with biotech and pharmaceutical companies. Production of crystalline proteins for laboratory use. R&D activities: Developing macromolecule crystallization methods. Developing new reagents for crystallization. Methods of technical handling of crystal batches. Core technologies: Crystallization of enzymes, proteins and peptides in large scale for commercial production purposes. Formulation of products on the basis of crystallization. Purification by crystallization. Categories of activity: Biotech company; Production; R&D service; Drug discovery; Biomaterials; Enzymes; Research reagents; |
Magnasense Ltd
Nanoscience Center, Survontie 9, FI-40500 JKL, Finland
Web site: www.magnasense.com
Founded: 2003
Personnel: 5 | Mika Laitinen, CEO
Phone: +358 40 5435989
Fax:
mika.laitinen(at)magnasense.com Jari Salmela, R&D Manager
Phone:
Fax:
jari.salmela(at)magnasense.com | R&D activities: Development of magnetometric lateral flow assay reader is going on. Magnasense also participates several research projects in the areas of magnetic particles and microfluidistics. Core technologies: Magnasense technology is based on the use of magnetic microspheres as labels and on the measurement of change on magnetization in the capture zone of a test. The diagnostic measuring instrument forms an easy to use quantitative biosensor when combined with disposable test cartridges. Either traditional sandwich assay or competitive assay formats can be used to form the capture zone.
Detection method is suitable for e.g. proteins, steroids, drugs of abuse, nucleic acids, bacteria and viruses. Categories of activity: Biotech company; R&D service; Supplier; Diagnostics and devices; |
Maininki PTC Oy
Kulttuuritehdas Korjaamo, Töölönkatu 51 B, FI-00250 Helsinki, Finland
Web site: www.maininki.com
Founded: 2004 | Sirpa Pietilä, CEO
Phone: +358 40 556 5268
Fax: +358 20 7417 001
sirpa.pietila(at)maininki.com | Production (and other) activities: Maininki PTC is specialized in effective communication and informative campaigns. Maininki PTC has special knowledge in biotechnology and is for example in charge of the national www.bioteknologia.info campaign. Categories of activity: Biotech support company; Other service; |
MAP Medical Technologies Oy
| | Categories of activity: |
MCA Research Laboratory Ltd
BioCity, Tykistökatu 6 B, FI-20520 Turku, Finland
Web site: www.mcaresearchlaboratory.com
Founded: 1992
Personnel: 4 (2006) | Markku Ahotupa, Chairman of the Board
Phone: +358 2 241 0142
Fax: +358 2 241 0143
res.lab(at)mca.inet.fi | Production (and other) activities: Biochemical and toxicological research services (laboratory studies and consulting) for industry and research institutions. R&D activities: Oxidative stress related diseases. Core technologies: Testing of antioxidant activity: from in vitro models to human studies. Availability of biomarkers for lipid, protein and DNA oxidation. Categories of activity: Biotech company; Biotech support company; R&D service; Supplier; Drug discovery; Diagnostics and devices; Food and feed; Environment; |
Meda Oy
| | Categories of activity: |
Medeia Therapeutics Oy
Microkatu 1, FI-70211 Kuopio, Finland
Web site: www.medeiatherapeutics.com
Founded: 2006 | Milla Koistinaho, CEO
Phone: +358-44-590 0603
Fax: +358-44-659 00603
milla.koistinaho(at)medeiatherapeutics.com | R&D activities: Medeia is engaged in the discovery and early development of novel therapies for diseases of the central nervous system. Categories of activity: Biotech company; R&D; Drug discovery; |
Medical Interscience Talents M.I.T. Consulting Ltd
Mannerheimintie 12 B, 5th floor, Helsinki
PO Box 16, FI-00601 Helsinki, Finland
Web site: www.mitconsulting.fi
Founded: 1990
Turnover: EUR 0,2 million (2005)
Personnel: 4 (2009) | Esa Soppi, President, CEO
Phone: + 358 40 524 2728
Fax: + 358 9 728 7064
esa.soppi(at)mitconsulting.fi | Production (and other) activities: Medical Interscience Talents M.I.T. Consulting Ltd “Doing things that stand viewing and reviewing in the arena of life sciences” provides services creating of added business value and hands on operational execution, as well as state of art methodology and innovative customized solutions to resolve challenging customer problems.
Strategy & operations:
1) Strategy audit & strategy development, 2) Portfolio and project assessment & value maximation, 3) Research & opportunity assessment, 4)Operative performance& process excellence.
Development services:
1) Refinement of drug & device development process, 2) Risk assessment & management, 3) CRO & central laboratory contracting, 4) SOP management process.
Core technologies: Proprietary methodology for portfolio management and valuation/value creation. Categories of activity: Biotech support company; R&D service; |
Medicall Finland Oy Ab
| | Categories of activity: |
MediCel Oy
Web site: www.medicel.com
Founded: 2001
Personnel: 45 (2005) | Risto Renkonen, Managing Director
Phone: +358 9 1912 5111 and
Fax: +358 9 1912 5155
| R&D activities: MediCel's Systems Biology software development aims to gather, sort, analyse and understand the wide diversity of biological data from various pre-existing databases as well as from our own biological experiments. We also annotate and generate systematically the biochemical pathways and finally convert the huge amount of biological data into knowledge. This will allow us to generate models of biological processes, which could be further tested and iterated by both in vitro, ex vivo and in vivo experiments. Categories of activity: Biotech company; R&D; Bioinformatics; |
Medifiq Healthcare Corporation
Äyritie 8 B, FI-01510 Vantaa, Finland
Web site: www.medifiq.com
Founded: 2006
Turnover: EUR 53 million (2005)
Personnel: 450 (2005) | Tomi Karvo, VP, Sales and Marketing
Phone: +358 40 544 9528
Fax: +358 (0)56291130
tomi.karvo(at)medifiq.com Juha Laiho, Manager, Technology development
Phone: +358 40 52 51296
Fax: +358 (0)9 56291130
juha.laiho(at)medifiq.com | Production (and other) activities: Medifiq is a leading solution provider for the healthcare industry. With proven expertise in product design, tooling, assembly and manufacturing, Medifiq is able to provide its customers only with the very best subcontracting solutions, always with optimum speed and reliability. R&D activities: High speed manufacturing of precision components and assemblies, materials application development, increasing the integration level of components Core technologies: Concept design, industrialization and mechanical design, prototyping and tooling, high volume precision injection moulding and assembly in clean room environment, filling and final packaging, logistics Categories of activity: Biotech company; Biotech support company; Production; R&D service; Supplier; Diagnostics and devices; |
MediFront Ltd.
Tykistökatu 6 B, FIN-20520 Turku, Finland
Web site: www.medifront.fi
Founded: 1999
Personnel: 3 | Tapio Rautaoja, Marketing Director
Phone: +358 2 4699254
Fax: +358 2 4699255
tapio.rautaoja(at)medifront.fi | Production (and other) activities: Markets special pharmaceuticals like orphan drugs to hospitals. Categories of activity: Biotech company; Supplier; Drug discovery; |
Medikalla Oy - MediPharmia
| Tuija Keinonen (Ph.D.Pharm.), Managing Director
Phone: +358 17 288 1231
Fax:
tuija.keinonen(at)medikalla.fi | Production (and other) activities: Contract manufactoring and packaging of pharmaceutical products. Analytical and microbiological analysis of pharmaceutical products and raw materials. R&D activities: Research and development of pharmaceuticals products. Categories of activity: Biotech company; Production; R&D service; |
Medikro Oy
| | Categories of activity: |
Medipolis GMP Oy
Kiviharjuntie 2, FI-90220 Oulu, Finland
Web site: www.medipolisgmp.com
Founded: 2001
Turnover: EUR 1 million
Personnel: 15 (2005) | Dr. Ashesh Kumar, Director
Phone: +358 400 207 380
Fax:
kumar.ashesh(at)medipolisgmp.com | Production (and other) activities: Medipolis GMP Ltd is a CMO that offers process development, fermentation, downstream and spporting QA / QC services for companies that need manufacturing of biopharmaceuticals for preclinical, clinical trials and even commercial purposes. We are looking for parters in EU for FP-7 program and offer our excellent team for process development and GMP material production for Clinical studies R&D activities: BioPAT- Process Development, Clinical Development of Biopharmaceuticals Core technologies: Microbial fermentation with related process development and downstream processes. Categories of activity: Biotech company; Production; |
Medix Biochemica Oy Ab
Asematie 13 , FI-02700 Kauniainen, Finland
Web site: www.medixbiochemica.com
Founded: 1985
Turnover: EUR 10,6 million (2008)
Personnel: 85 (2008) | Mr. Ismo Råman, Managing Director
Phone: +358 9 547680
Fax: +358 9 5053441
ismo.raman(at)medixbiochemica.com | Production (and other) activities: Production Monoclonal antibodies and rapid diagnostic tests. R&D activities: Monoclonal antibodies and rapid diagnostic tests. Core technologies: Antibody technology and applications. Categories of activity: Biotech company; Production; R&D; Diagnostics and devices; |
Melius Pharma Oy
| | Categories of activity: |
Merck Oy
| | Categories of activity: |
MetGen Oy
| | Categories of activity: |
Metkinen Oy
| | Categories of activity: |
Mobidiag Oy
Haartmaninkatu 8 (Biomedicum), FI-00290 Helsinki, Finland
Web site: www.mobidiag.com
Founded: 2000
Personnel: 13 (2005) | Jaakko Pellosniemi, CEO
Phone: +358 9 191 25021
Fax: +358 9 191 25020
jaakko.pellosniemi(at)mobidiag.com Sari Valasti, Office Manager
Phone: +358 9 191 25021
Fax: +358 9 191 25020
sari.valasti(at)mobidiag.com | Production (and other) activities: Mobidiag´s core products are DNA biochips for the rapid identification of important microbial pathogens directly from patient samples. R&D activities: Mobidiag is developing solutions for the user-friendly and cost-effective analysis of biochip test results. Core technologies: Mobidiag´s technology uses a patented univelsal approach to identify microbial species. This technology allows the rapid simultaneous detection of a large panel of organisms from a single sample. Categories of activity: Biotech company; R&D; Diagnostics and devices; Bioinformatics; |
MSD Finland Oy
| | Categories of activity: |
MTT
Agrifood Research Finland
| | Categories of activity: |
Mylab Oy
Hatanpään valtatie 26, FI-33100 Tampere, Finland
Web site: www.mylab.fi
Founded: 1987
Turnover: EUR 9 million (2008)
Personnel: 53 (2008) | Esa Soini, CEO
Phone: +358 3 3165165
Fax: +358 3 3165166
Jukka Kalliosaari, Corporate Relations Manager
Phone: +358 3 3165165
Fax: +358 3 3165166
| Production (and other) activities: Mylab produces information services and IT systems for clinical laboratories R&D activities: Business intelligence, systems integration, automated verification, advanced LIS, analyzer interfaces and web-based applications Categories of activity: Biotech support company; |
Mzymes Oy
| | Categories of activity: |
Nab Labs Oy
Betonimiehenkuja 1 A, 02150 Espoo
Web site: www.nablabs.fi
Founded: 2003
Turnover: EUR 8 million (2008)
Personnel: 120 (2009) | Mikko Sainio, VP, Business Development
Phone: +358 40 588 1679
Fax:
mikko.sainio(at)nablabs.fi Markku Ahponen, CEO
Phone: +358 40 543 7887
Fax:
markku.ahponen(at)nablabs.fi | Production (and other) activities: Nab Labs provides a wide scope of laboratory services. Ad hoc samples or long-term analytical support contracts. Categories of activity: Biotech support company; R&D service; Other service; |
Nanobac Oy
Neulaniementie 2 L 14, FI-70210 Kuopio, Finland
Web site: www.nanobac.com
Founded: 1998
Personnel: 7 | Olavi Kajander, Managing Director
Phone: +358 17 265 8900
Fax: +358 17 265 8933
olavi.kajander(at)nanobac.com Katja Aho, Director R&D
Phone: +358 17 265 8900
Fax: +358 17 265 8933
katja.aho(at)nanobac.com | Production (and other) activities: Components and test assays for nanobacteria detection, like antigen and antibody detection by ELISA assays and quick test. Core technologies: Culture systems, antigen and antibody detection methods. Categories of activity: Biotech company; Production; R&D; R&D service; Other service; Supplier; Drug discovery; Diagnostics and devices; Biomaterials; |
Net-Foodlab Ltd
Voimakatu 19, FIN-20520 Turku, Finland
Web site: www.netfood.fi
Founded: 1997
Personnel: 10 | Tuomas Virtalaine, M.Sc.
Phone: +358 2 2730 891
Fax: +358 2 2730 880
tuomas.virtalaine(at)netfood.fi Anu Johansson, Ph.D.
Phone: +358 2 2730 893
Fax: +358 2 2730 880
anu.johansson(at)netfood.fi | Production (and other) activities: Analytical laboratory services. Production hygiene and quality control services. Distribution, method development and validation for Celsis and Hygiena rapid diagnostics systems. Categories of activity: Biotech support company; R&D service; Other service; Supplier; Diagnostics and devices; Food and feed; Environment; |
Nexstim Oy
| | Categories of activity: |
Next Biomed Technologies NBT Oy
Biomedicum Helsinki 2U, Tukholmankatu 8, FI-00290 Helsinki, Finland
Web site: www.nextbiomed.com
Founded: 2006
Personnel: 12 (2009) | Ilari Antila, CEO
Phone: +35894540420
Fax: +35894540421
ilari.antila(at)nextbiomed.com Ville Tieaho, Director of R&D
Phone: +35894540420
Fax: +35894540421
ville.tieaho(at)nextbiomed.com | Categories of activity: Biotech company; Production; R&D; Diagnostics and devices; |
NNE Pharmaplan
Finland
| | Categories of activity: |
Nordic Envicon Oy
| | Categories of activity: |
Norlab Ltd
| | Categories of activity: |
Novagenesis Oy
Biomedicum Helsinki 2 U, Tukholmankatu 8, FIN-00290 Helsinki, Finland
Founded: 2006
Personnel: 9 (2009) | Kauko Kurkela, Managing Director
Phone: +358 50 310 6848
Fax: +358 10 440 5401
kauko.kurkela(at)novagenesis.fi | R&D activities: The Company specializes in the development of unique regeneration products for nervous system. Categories of activity: Biotech company; R&D; Diagnostics and devices; |
Novamass Ltd
Kiviharjuntie 11, FIN-90220 Oulu, Finland
Web site: www.novamass.net
Founded: 2002
Personnel: 11 (2009) | Jouko Uusitalo, CEO
Phone: +358 207 639 669
Fax: +358 207 639 660
jouko.uusitalo(at)novamass.net | Production (and other) activities: We provide ADME contract research for drug discovery and development. Our core competences are in vitro drug metabolism studies (metabolic stability and metabolite identification), metabolism related drug interaction studies, and permeation studies of NCEs and related pharmacology. We also provide custom analysis based on LC/MS and NMR techniques and quantitative bioanalysis (eg. in vivo animal DMPK studies). R&D activities: Our services include metabolic stability, metabolite identification, metabolizing CYP enzyme identification, CYP inhibition and induction, cell line permeation, BBB penetration and in vivo metabolism studies. Our studies predict in vivo ADME properties of NCEs in man and are used to lead optimisation and selection of candidate drugs. Core technologies: Human and animal liver preparations. Determination of physicochemical ADME parameters, protein binding and permeability. Chemical purity and degradation. Liquid Chromatography combined with Mass Spectrometry (LC/MS), NMR. Analytical method development and validation. Bioanalysis. Categories of activity: Biotech support company; R&D service; Drug discovery; |
Novobion Oy
| | Categories of activity: |
Oligomer Oy
Latokartanonkaari 11, D-talo, 00790 Helsinki, Finland
Web site: www.oligomer.fi
Founded: 2004
Turnover: EUR 0,5 million (2009)
Personnel: 3 (2009) | Veli-Pekka Karvinen, Managing Director
Phone: +35897552550
Fax: +358975525555
veli-pekka.karvinen(at)biofellows.com Matti Laakso, Production Chemist
Phone: +358934789010
Fax: +358934789090
matti.laakso(at)oligomer.fi | Production (and other) activities: Production of synthetic oligonucleotides, DNA and RNA. Categories of activity: Biotech company; Production; R&D; Research reagents; |
OneMed Oy
PO Box 11, FI-01641 Vantaa, Finland
Web site: www.onemed.com
Founded: 1999
Turnover: EUR 200 million (2006)
Personnel: 14 (2006) | Aarno Saarelainen, Marketing Manager
Phone: +358 20 445 4720
Fax: +358 20 445 4717
aarno.saarelainen(at)onemed.com | Production (and other) activities: Sales and marketing of Life Science products for biotech and drug discovery companies. Categories of activity: Biotech support company; Supplier; Research reagents; |
Optomed Oy (Ltd)
Hallituskatu 13-17 D 96, FI-90100 Oulu, Finland
Web site: www.optomed.fi
Founded: 2004
Turnover: EUR 0,05 million (2008)
Personnel: 10 (2008) | Seppo Kopsala, CEO
Phone: +358 40 555 1050
Fax:
seppo.kopsala(at)optomed.fi | Production (and other) activities: Optomed Oy is a pioneering medical technology company that specializes in digital imaging devices both for human and veterinary medicine. Categories of activity: Biotech support company; R&D; Diagnostics and devices; |
OrFix Oy
| | Categories of activity: |
Orion Corporation
Orion Pharma
Orionintie 1 A, PO Box 65, FI-02101 Espoo, Finland
Web site: www.orionpharma.com
Founded: 1917
Turnover: EUR 641,1 million (2006)
Personnel: 3 061 (total) (2006) | Matti Vaheri, Director, CNS Business
Phone: +358 10 4261
Fax: +358 10 426 3815
matti.vaheri(at)orionpharma.com Reijo Salonen, Senior Vice President, Research & Development
Phone: +358 10 4261
Fax: +358 10 426 3600
reijo.salonen(at)orionpharma.com | Production (and other) activities: Production pharmaceuticals, active pharmaceutical ingridients and diagnostic point of care -test systems. R&D activities: Drug discovery and development on three core therapeutic areas: CNS, cardiovascular diseases and critical care, hormone replacement therapies and urology, as well as animal health. Core technologies: All major techniques for drug development from molecule to market. Categories of activity: Biotech company; Production; R&D; Drug discovery; Diagnostics and devices; |
Orion Diagnostica Oy
PO Box 83, FI-02101 Espoo, Finland
Web site: www.oriondiagnostica.fi
Founded: 1974 (as an independent divisi
Turnover: EUR 39,3 million (2004)
Personnel: 318 (2004) | Jaakko Rissanen, President
Phone: + 358 10 429 4858
Fax: + 358 10 429 2794
jaakko.rissanen(at)oriondiagnostica.fi | Production (and other) activities: Production, sales and marketing of Diagnostic tests and test systems, monoclonal antibodies, protein purifucation and modification, dip-slide manufacturing, Large scale antibody production (poly and mono), Microparticles. R&D activities: Focusing on point of point-of-care test systems and special analytes: H. pylori, CRP, bone markers, anemia markers, steroid hormones. Core technologies: Analyte know-how, Multiple assay technologies, Microparticle technology. Categories of activity: Biotech company; Production; R&D; Supplier; Diagnostics and devices; |
Orthotopix Ltd
| | Categories of activity: |
Osteofix Oy
| | Categories of activity: |
Oulu Innovation Oy / Bio Forum Oulu
Elektroniikkatie 6, FI-90570 Oulu, Finland
Web site: www.ouluinnovation.com
Founded: 2004 | Olli Löytynoja, Vice President
Phone: +358 8 551 3005
Fax: +358 8 551 3627
olli.loytynoja(at)ouluinnovation.com Tuula Palmén, Program Director
Phone: +358 50 461 7290
Fax: +358 207 545 879
tuula.palmen(at)bioforumoulu.org | Production (and other) activities: Development projects within Life Sciences incl. biotechnology. The convergence of BIO with Nano, IT and Eco. Categories of activity: Biotech support company; Other service; |
Oy Cardiocode-Finland Ltd.
| | Categories of activity: |
Oy Medfiles Ltd
Volttikatu 5, FI-70700 Kuopio, Finland
Web site: www.medfiles.fi
Founded: 1987 | Tuija Keinonen, Managing Director, Ph.D.Pharm.
Phone: +358 20 7446 802
Fax: +358 20 7446 801
tuija.keinonen(at)medfiles.fi Maire Mäkimartti, Key Account Manager, M.Sc. (Pharm.)
Phone: +358 9 8494 5723
Fax: +358 9 8494 5710
maire.makimartti(at)medfiles.fi | Production (and other) activities: MedFiles Ltd is a private pharmaceutical service company, a unique combination of CMO and CRO with strong, over 20 years, experience. In Europe, our geographical focus is in Scandinavian countries (Finland, Sweden, Denmark, Norway) and Baltic states (Estonia, Latvia and Lithuania). The areas of expertise include pharmaceutical development, product updating and full range of analytical services (chemical and microbiological), clinical research services (phase I to IV studies) and marketing authorisation services (regulatory affairs). Additionally, MedFiles has access to contract manufacturing and packaging to provide you with the total service package. R&D activities: Research and development of pharmaceutical products Categories of activity: Biotech company; R&D; R&D service; Other service; |
Patiq Oy
Westendintie 1b FI-02160 Espoo
Web site: www.patiq.com
Founded: 2007 | Antti Pirnes, Chairman, Patent Analyst
Phone: +358 10 4211302
Fax: +358 10 4211309
antti.pirnes(at)patiq.com | Production (and other) activities: Patiq is a Finland based technology intelligence company. We use the most powerful commercial data banks to analyze patent information on product, technology and market changes in order to increase our client’s decision-making quality and competitiveness. Our promise to you is to guide you to stay on track in your research and development projects, enable you to commercialize your technology and stay ahead of your competitors. We are a company with several years of expertise in patent analysis in various technology fields.
Categories of activity: Biotech support company; R&D; R&D service; Other service; Drug discovery; Diagnostics and devices; Biomaterials; Bioinformatics; Food and feed; Agro; Environment; Enzymes; Research reagents; |
PCAS Finland Oy
Messukentänkatu 8, FI-20101 Turku, Finland
Web site: www.pcasfinland.fi
Founded: 1960
Turnover: EUR 11 million (2004)
Personnel: 120 (2004) | Jussi Torikka, President
Phone: +358 2 3305457
Fax: +358 2 3305500
info(at)pcasfinland.com Reino Isotalo, Sales Director
Phone: +358 2 3305907
Fax: +358 2 3305500
info(at)pcasfinland.fi | Production (and other) activities: PCAS Finland Oy develops, manufactures and markets fine chemicals for the pharmaceutical industry.
Our product portfolio consists of Active Pharmaceutical Ingredients (APIs) and Custom Manufactured Products for our clients.
R&D activities: We provide the following R&D services for our clients:
development of laboratory synthesis for new chemical entities, scaling-up processes to a commercial scale, development of analytical procedures to be used in quality control
The key areas of our research and development are:
synthetic research and development, reaction calorimetry for safety studies, analytical research and development, assistance for regulatory documentation.
Core technologies: The key technologies used in custom manufacturing are:
chlorination (chlorine in bulk), hydrogenation, optical resolution, bisphosphonate chemistry, reduction with alkyl metal hydrides, final processing for parenteral/injectable APIs.
PCAS Finland Oy also relies on PCAS S.A. corporate resources (6 plants) for cGMP (300 m3 reactor volume) and non GMP (400 m3 reactor volume) chemical synthesis.
Categories of activity: Production; R&D; R&D service; Other service; Supplier; Drug discovery; |
PerkinElmer Wallac Oy
Mustionkatu 6, FIN-20101 Turku, Finland
Web site: www.perkinelmer.com
Founded: 1950
Turnover: EUR 100 million
Personnel: 650 | Hanna Halme, General Manager
Phone: +358 2 267 8339
Fax: +358 2 267 8357
hanna.halme(at)perkinelmer.com Kauko Lamminpää, Sales Manager
Phone: +358 2 267 8464
Fax: +358 2 267 8305
kauko.lamminpaa(at)perkinelmer.com | Production (and other) activities: Production Final assembly and testing of instruments, reagent production and labelling service. R&D activities: Research of new technologies related to genetic screening and drug discovery applications. Product development regarding total solutions including instrumentation, chemistry and software. Applications for clinical diagnostics, bioanalytical research and drug discovery. Categories of activity: Biotech company; Production; R&D; Diagnostics and devices; |
Pfizer Oy
| | Categories of activity: |
PG Quality Oy
| | Categories of activity: |
Pharmatest Services Ltd
Itäinen Pitkäkatu 4 C, 5th floor, FI-20520 Turku, Finland
Web site: www.pharmatest.fi
Founded: 1997
Turnover: EUR 0.7 million (2008)
Personnel: 14 (2008) | Jussi Halleen, CEO
Phone: +358 50 3809551
Fax: +358 2 2784710
jussi.halleen(at)pharmatest.fi | R&D activities: Development of new in vitro and in vivo methods useful for pre-clinical testing of drug candidates for osteoporosis and related bone disorders. Core technologies: Various in vitro and in vivo models useful for pre-clinical testing of drug candidates for osteoporosis and related bone disorders. Categories of activity: Biotech company; R&D; Other service; |
Pharmatory Ltd
PO Box 346, FI-90101 Oulu, Finland
Web site: www.pharmatory.com
Founded: 2001
Turnover: EUR 2-3 million (2008)
Personnel: 23 (2009) | Jaana Karjalainen, Managing Director
Phone: +358 44 270 7271
Fax: +358 20 765 9985
jaana.karjalainen(at)pharmatory.com Johanna Heffernan, International Marketing & Logistics Manager
Phone: +358 40 502 5281
Fax: +358 20 765 9985
johanna.heffernan(at)pharmatory.com | Production (and other) activities: Pharmatory specializes in the custom contract research and development and cGMP manufacturing of the APIs and the key intermediates from micro to pilot scale. The key components in all projects are customer intimacy and operational excellence with high confidentiality. Pharmatory is routinely inspected by the regulatory authorities since 2001. R&D activities: State-of-the-art analytical facility, stability studies according to ICH guidelines, impurity profiling, broad range expertise of the organic chemistry, process optimization, labelling services, identification of critical process parameters. Core technologies: Process validation at the level of regulatory authorities documentation, class C clean room area for final handling, control of the API development process, the quality and regulatory know-how, characterization of chiral molecules. Categories of activity: Biotech support company; Production; R&D; R&D service; Drug discovery; |
Pharmavir Oy
Aapontie 11 B 1, FI-02180 Espoo, Finland
Founded: 2003
Personnel: 1 (2004) | Kauko Kurkela, President and CEO
Phone: +358 500 536 742
Fax: +358 9 502 3591
| Production (and other) activities: Pharmavir offers expert consulting services in the field of pharmaceutical, biotech and biomaterial industry. Management, R&D, business development, product and product portfolio strategy and planning. Consulting services both in strategic- and operational areas. Categories of activity: Biotech support company; Other service; Drug discovery; Diagnostics and devices; Biomaterials; |
Pharmia Oy
Kalliotie 2, FI-04360 Tuusula, Finland
Web site: www.pharmia.com
Founded: 1993
Turnover: EUR 4,9 million (2008) | Kari Pulkkinen, Managing Director
Phone: +358 9 8254 030
Fax: +358 9 870 9715
info(at)pharmia.fi | Production (and other) activities: Contract manufacturing, product development and formulation of Food supplements and Medical Decice Class I. Product forms : tablets, hard gelatin capsules, liquids and powder-mixes. Packaging in blisters, jars, bottles and cartons. Categories of activity: Biotech support company; Production; R&D; Food and feed; |
PLD Finland Oy
Hannuksentie 1, 02270 ESPOO, Finland
Web site: www.pld.fi
Founded: 1998
Turnover: EUR 2 million (2009)
Personnel: 10 (2009) | Tomi Virtanen, Managing Director
Phone: +358 207 410 270
Fax: +358 207 410 270
| Core technologies: PLD Finland Oy is a leading supplier of laboratory instruments, consumables and reagents.
Our core competence is in laboratory automation, microtiter plate instruments, cell and molecular biology, clean room technology and in cryo technical products.
Our biggest suppliers are Tecan, Caliper Life Sciences, PAA Laboratories, Porvair Sciences, Varian, Büchi, MVE Chart and Planer Biomed.
Feel free to contact us by email sales[at]pld.fi.
Our web pages You can find at www.pld.fi Categories of activity: Biotech support company; Other service; Supplier; Diagnostics and devices; Research reagents; |
PlexPress Oy
Tekniikantie 21, FI-02150 Espoo, Finland
Web site: www.plexpress.fi
Founded: 2007
Personnel: 4 (2007) | Juhani Lahdenperä, CEO
Phone: 050-3669502
Fax:
juhani.lahdenpera(at)plexpress.fi | Production (and other) activities: Service, kit & software manufacturing enabling multiplex gene expression analyses by TRAC. PlexPress has been noted to be the one of the most successful start-up:s in Finnish Biotech sector last year. PlexPress is a spin-out company of VTT (Technical Researh Center of Finland). R&D activities: TRAC platform development. Core technologies: TRAC (TRanscriptional Analysis with aid of affinity Capture) technology uniquely satisfies the gene fingerprint/function analysis market requirements. Its efficiency, flexibility and reliability are superior at the market place. TRAC technology enables the analysis of tens of genes from hundreds of samples in high efficient manner compared to current offering by other companies. Categories of activity: Biotech company; Production; Research reagents; |
Pohjoisen Kantaperuna/ Northern Seed Potato
| | Categories of activity: |
Polttimo Companies Ltd
PO Box 22, FI-15141 Lahti, Finland
Web site: www.polttimo.com
Founded: 1883
Turnover: EUR 87 million (2004)
Personnel: 233 (2004) | Katharina Stenholm, CEO
Phone: +358 3 864 11
Fax: +358 3 781 0823
katharina.stenholm(at)polttimo.com Juha Ylä-Anttila, Business Development Director
Phone: +358 3 864 11
Fax: +358 3 752 2742
juha.yla-anttila(at)polttimo.com | Production (and other) activities: Production Yeast, malt and malt extracts. R&D activities: LP Research Centre Ltd. Core technologies: Fermentation, malting, extraction, separation, concentration. Categories of activity: Biotech company; Production; Food and feed; |
Premedic Clinical Research Ltd
| | Categories of activity: |
PricewaterhouseCoopers Oy
| | Categories of activity: |
Primus International Oy Ltd
Iso Roobertinkatu 3-5 D 10, FI- 00120 HELSINKI, Finland
Web site: www.primusfives.com
Founded: 1998
Personnel: 1 | Arja Kuittinen, CEO, M.Sc.(Biol), BBA, TMC
Phone: +358 50 300 0351
Fax:
arja.kuittinen(at)primusfives.com | Production (and other) activities: Services to small and mid-size Finnish and Global companies with a special expertise in Life Sciences, Biotechnology and CRO. Proven track record and experience in Turnaround of Finnish Operations of a Global Corporate and Local SME’s, Re-organization and Restructuring, Strategic Partnerships, Interim CEO and Executive Board Memberships, Global and Local Networks, Fund raising from Venture Capital Organizations, Internationalisation processes, Leadership and Business Operations Management.
Categories of activity: Biotech support company; Other service; |
Project Consult Technopro Oy
Tuomiokirjkonkatu 3 d 24
Web site: www.technopro.fi
Founded: 1988
Turnover: EUR 0,3 million (2008)
Personnel: 1 (2008) | Pekka J Nieminen, Man.dir
Phone: +358 400 620453
Fax: +358 10 296 0622
pekka.nieminen(at)technopro.fi | Production (and other) activities: Agent of LSMW GmbH Germany in Finland and Estonia Categories of activity: Biotech support company; Other service; |
Quintiles Oy
| | Categories of activity: |
Raisio plc
| | Categories of activity: |
Reactionlab Oy
PO Box 120, FI-20521 Turku, Finland
Web site: www.reaction-lab.com
Founded: 2001 | Olli Suominen
Phone: +358 40 778 9838
Fax: +358 2 4101123
olli.suominen(at)reaction-lab.com | Production (and other) activities: Reactionlab is offering marketing services in Nordic countries in the fields of diagnostics and biotechnology. Core technologies: Molecular Biology, Molecular Medicine,Food and Pharmaceutical Research, Immunoassay, Luminescence, Fluorescence, Transfections,Liquid Handling, Special Reagents. Categories of activity: Biotech support company; Other service; Diagnostics and devices; |
Reagena Oy Ltd
Takojantie 18, FI-70900 Toivala, Finland
Web site: www.reagena.fi
Founded: 1987
Turnover: EUR 1,3 million (2008)
Personnel: 16 (2008) | Dr Markku Parviainen, PhD, Managing Director, CEO
Phone: +358 17 368 8504
Fax: +358 17 368 8530
markku.parviainen(at)reagena.fi Ms Kati Ryynänen, MSci, Marketing Manager
Phone: +358 17 368 8505
Fax: +358 17 368 8530
kati.ryynanen(at)reagena.fi | Production (and other) activities: Production of in vitro diagnostic (IVD) products such as biological staining solutions and test kits. Manufacturer of ReaMobile™ point-of-care diagnostic system with different POC tests. Reagents according to Ph.Eur. Along with the product line of high quality liquid-based reagents, we are engaged in contract development and production for other industries. We supply liquid-based reagents and solutions to our industrial partners as contract manufacturer.
R&D activities: Point-of-care testing (R&D, manufacturing, commercialisation of innovations). Core technologies: New ReaMobile™ Test System is based on REASCAN™ rapid test reader with ReaLink™ Bluetooth device and ReaMobile™ software on a mobile phone or a PC, and our new proprietary immuno-chromatography technology. The ReaMobile™ test system is versatile for quantitative and qualitative applications in clinical chemistry, virology, and microbiology.
Categories of activity: Biotech company; Production; R&D; R&D service; Supplier; Diagnostics and devices; Research reagents; |
Regea Institute for Regenerative Medicine
Biokatu 12, 33520 Tampere
Web site: www.regea.fi
Founded: 2003
Turnover: EUR 3,5 million (2008)
Personnel: 50 (2009) | Riitta Suuronen, Director, Professor
Phone: +358 400 473 640
Fax: + 358 3 3551 8498
riitta.suuronen(at)regea.fi | Production (and other) activities: The Regea Institute for Regenerative Medicine is a joint institute under the administration of the University of Tampere, having been founded by the University of Tampere, Tampere University of Technology, Pirkanmaa Hospital district, Pirkanmaa University of Applied Sciences and the Coxa Hospital for Joint Replacement.
Regea engages in research in cell and tissue engineering, the focal areas being stem cell research and research combining stem cells and biomaterials.
Regea Tissue Bank meets the requirements of the current Finnish legislation and also EU Directives for tissue banking. It processes and supplies tissues for clinical use.
The business idea of Regea also extends to improving the operating preconditions of research groups and companies in the field. Some of the Regea laboratory and cleanroom facilities and equipment are available for rent to research groups and enterprises and for training purposes. R&D activities: Regea's stem cell research aims at developing new clinical treatments utilizing cell and tissue engineering as well as regenerative medicine. Core technologies: Tissue engineering, regenerative medicine, stem cell research. Categories of activity: Biotech centre; Production; R&D; Other service; |
Remedal Oy
| | Categories of activity: |
Replicon Oy
ALeksanterinkatu 17, P.O.Box 800, FIN-00101, Helsinki, Finland
Web site: www.replicon.fi
Founded: 1993
Turnover: EUR 0,15 million (2008)
Personnel: 4 (2008) | Petteri Hirvonen, CEO
Phone: +358 50 552 96 33
Fax: +358 10 2960313
petteri.hirvonen(at)replicon.fi | Production (and other) activities: Replicon Group provides investment bank services and strategic solutions that facilitate business activities, efficiency, and increase the profitability of corporations and other organizations. Replicon Group's special focus areas are Life Science, Cleantech and ICT sectors. Our core services include: - Corporate Finance - Valuation services - Strategic consulting - Business Plans - R&D activities: Research on listed US biotech companies performance (Replicon Biotech Model portfolio) Core technologies: Monte Carlo simulations in drug development Categories of activity: Biotech support company; Other service; Drug discovery; Diagnostics and devices; Environment; |
Rintekno Group
PO Box 146, FI-02101 Espoo, Finland
Web site: www.rintekno.com
Founded: 1970
Turnover: EUR 25 million (2006)
Personnel: 230 (2006) | Esa Aittomäki, Marketing Director
Phone: +358 9 46 98 331
Fax: +358 9 466 311
esa.aittomaki(at)rintekno.fi Reino Kalmari, Executive Vice President
Phone: +358 9 4698 362
Fax: +358 9 466 311
reino.kalmari(at)rintekno.fi | Production (and other) activities: Full range of engineering and project management services for the Life Science Industry and Chemical Process Industry. We design and build production facilities beginning with a process development as a partner in client's R&D team and going through pilot scale tests to a commissioned and validated plant. We deliver pilot and production scale facilities on turn-key basis as well. We have designed and built R&D facilities and production scale plants for blood plasma fractionation, fermentation, enzyme manufacturing, pharmaceutical production, food stuff and natural extractives production. R&D activities: Client specific modelling of processes and unit operations, process development, scale-up and process optimization. Core technologies: Engineering, Procurement, Construction and Project Management services. Commissioning and Start-up services. Conceptual design, Basic engineering and Project implementation services. Process development and simulation services. Validation services. Project and process risk assessment. Plant Life Cycle analysis. Hazard process analysis. Categories of activity: Biotech support company; Other service; Supplier; Food and feed; Agro; Environment; Enzymes; |
Roal Oy
PO Box 57, Tykkimäentie 15, FI-05201 Rajamäki, Finland
Web site: www.roal.fi
Founded: 1992
Turnover: EUR 33 million (2007)
Personnel: 102 (2009) | Pekka Kekki, Managing Director
Phone: +358 9 29042 140
Fax: +358 9 29042 114
pekka.kekki(at)roal.fi Jari Vehmaanperä, Research Director
Phone: +358 9 29042 120
Fax: +358 9 29042 112
jari.vehmaanpera(at)roal.fi | Production (and other) activities: Industrial enzymes for food, feed, beverage, textile, detergent and P&P applications. R&D activities: Discovery and cloning of novel enzymes for existing and new applications. Strain improvement and process development. Core technologies: Trichoderma production technology. Industrial enzymes (particularly cellulases and hemicellulases). Categories of activity: Biotech company; Production; R&D; Supplier; Enzymes; |
Roschier
Attorneys Ltd.
| | Categories of activity: |
Sanquin Oy
| | Categories of activity: |
Santen Oy
| | Categories of activity: |
Scaffdex Oy
P.O.Box 27, FI-33411 Tampere, Finland Kalkunkatu 21 B, FI-33330 Tampere, Finland
Web site: www.scaffdex.com
Founded: 2006
Personnel: 3 (2006) | Tuija Annala, Managing Director
Phone: +358-40-505 3351
Fax:
tuija.annala(at)scaffdex.com | Production (and other) activities: Tissue engineering means the renewal processing of biological tissues by means of cells, support structures and/or biomolecules. Scaffdex Oy provides researchers and the industry of the professional area CellCrown cell culture inserts and various biodegradable structures, which are suitable for cell culture studies. R&D activities: Scaffdex Oy works in close cooperation with the technical institutes of fibre materials science and biomaterials of Tampere University of Technology and Regea Institute for Regenerative Medicine as well as with many other international cooperation partners.
Core technologies: Expertise in various biomaterials, fibres and textile structures Categories of activity: Biotech company; Biomaterials; |
Serres Oy
| | Categories of activity: |
SLP Innovations Oy
Tykistökatu 4D, FI-20520 Turku, Finland
Web site: www.slpinnovations.com
Founded: 2006 | Sanna Paakkonen, Managing Director
Phone: +358408418283
Fax: +358 2 4101710
sanna(at)slpinnovations.com | Production (and other) activities: SLP Innovations offers a range of solutions that will enhance the commercialisation and internationalisation of biotechnology. These solutions includes International Technology Transfer, R&D Partnering, Biobusiness Training and Roadshows. The services allow you to choose the combination of solutions that best fits the stage of your technological development and the specific goals for which you may require external services. Categories of activity: Biotech support company; Other service; |
Software Point Oy
Valkjärventie 1, FIN-02130 Espoo, Finland
Web site: www.softwarepoint.com
Founded: 1992
Turnover: EUR 5 million
Personnel: 30 | Andrea Holmberg, Managing Director
Phone: +358 9 4391 320
Fax: +358 9 4391 3211
info(at)softwarepoint.fi | Production (and other) activities: Software Point provides information management software for laboratories, quality control and research. Categories of activity: Biotech support company; Other service; |
SoluCel Ltd
| | Categories of activity: |
StatFinn Oy
Linnankatu 9 b A 1
Web site: www.statfinn.fi
Founded: 2005
Personnel: 9 (2009) | Pekka Heikkilä, CEO
Phone: +358503216006
Fax:
pekka.heikkila(at)statfinn.fi Pasi Korhonen, CSO
Phone: +358503652990
Fax:
pasi.korhonen(at)statfinn.fi | Production (and other) activities: We provide statistical and data management services to customers conducting experimental research in the various fields of life sciences. Our focus is on proper application of statistical methods in planning, analysis and reporting of clinical and non-clinical studies. Full scale CRO services from planning to final report are provided together with our partners.
Categories of activity: Biotech support company; R&D service; Other service; Drug discovery; Diagnostics and devices; Biomaterials; Food and feed; |
Stick Tech Ltd
P.O.Box 114, FIN-20521 Turku, Finland
Web site: www.sticktech.com
Founded: 1997
Personnel: 13 (2009) | Jyrki Kurokallio, Managing Director
Phone: +358 2 4808 2500
Fax: +358 2 241 0032
jyrki.kurokallio(at)sticktech.com | Production (and other) activities: Production fibre reinforcements R&D activities: Research with fibre reinforcements with worlds top researchers and universities. Core technologies: Fibre reinforcements Categories of activity: Biotech company; R&D; Biomaterials; |
Syngenta Crop Protection A/S
Finnish subsidiary
PO Box 124, FI-10301 Karjaa, Finland
Web site: www.syngenta.com
Founded: 2001 | Risto Knaapinen, Business manager
Phone: + 358 19 236 106
Fax: + 358 19 236 108
risto.knaapinen(at)syngenta.com Arto Markkula, Crop Manager
Phone: + 358 2 436 7151
Fax: + 358 2 436 7161
arto.markkula(at)syngenta.com | Production (and other) activities: Marketing Crop Protection products. R&D activities: Development in the field of crop protection and seeds. Categories of activity: Biotech support company; Supplier; Agro; |
SYRINX Bioanalytics Oy
| | Categories of activity: |
Systems Biology Worldwide Oy
Mikonkatu 8, FI-00100 Helsinki
Web site: www.systemsbiology.fi
Founded: 2007 | Juho Eväsoja, CEO
Phone: +358 40 730 2313
Fax: +358 9 678 783
juho.evasoja(at)systemsbiology.fi Juha Saharinen, CTO
Phone: +358 40 528 1973
Fax: +358 9 678 783
juha.saharinen(at)systemsbiology.fi | Production (and other) activities: We offer services in the area of:
* Efficacy studies
* In vitro ADMET
* Safety studies
* In vivo PK and bioanalytics
* Discovery informatics
Categories of activity: Biotech support company; R&D service; Drug discovery; Bioinformatics; |
Tammer-Tutkan Maljat Oy
| | Categories of activity: |
Technopolis Kuopio Oy
| | Categories of activity: |
Technopolis Ventures Kuopio Oy
| | Categories of activity: |
Technopolis Ventures Oulutech
| | Categories of activity: |
Teriaka Ltd
| | Categories of activity: |
Terivan Oy
| | Categories of activity: |
Ternics Oy
Riitankuja 7 A 11, FI-00840 Helsinki, Finland
Web site: www.ternics.com
Founded: 1993
Personnel: 1 (2005) | Erkki Tikkanen, CEO
Phone: +358 9 6987 087
Fax: +358 9 6228 0332
tikkanen(at)ternics.inet.fi | Production (and other) activities: Management consulting, business and financing plans, numerical and investment analysis, acquisitions etc for health care and life science companies.
Strategy studies and portfolio analysis for Public Actors and Life Science Centers and Venture Capital companies. Categories of activity: Biotech support company; Other service; Drug discovery; Diagnostics and devices; Biomaterials; Bioinformatics; Food and feed; Agro; Environment; Enzymes; Research reagents; |
The A. I. Virtanen Institute for Molecular Sciences (AIVI)
| | Categories of activity: |
Thermo Fisher Scientific Oy
Ratastie 2, PO Box 100, FI-01621 Vantaa, Finland
Web site: www.thermo.com
Founded: 1971
Turnover: EUR 120 million (2008)
Personnel: 560 (2008) | Timo Hildén, President
Phone: +358 9 329 100
Fax: +358 9 3291 0500
timo.hilden(at)thermofisher.com | Production (and other) activities: Pipettes and consumables, Clinical Chemistry Analyzers and reagents, Clinical laboratory automation systems, Microplate instrumentation and magnetic particle instruments, Automated systems for analysis of water and environmental samples R&D activities: Liquid Handling, Detection instruments, Clinical chemistry analyzers and reagents, Automation. Core technologies: Liquid Handling, Detection instruments, Clinical chemistry analyzers and reagents, Automation. Categories of activity: Biotech company; Production; R&D; Diagnostics and devices; Environment; |
Toxis Ltd
Lemminkäisenkatu 14-18 C, 20520 TURKU
Web site: www.sbw.fi; www.toxis.fi
Founded: 2005
Turnover: EUR 0,5 million (2008)
Personnel: 9 (2008) | Mari Madetoja, CEO
Phone: +358 40 5190266
Fax: +358 2 236 0370
mari.madetoja(at)sbw.fi | Production (and other) activities: Toxis provides customizable services in in vivo disease models, safety pharmacology and toxicology, and pharmacokinetics.
Toxis is a subsidiary of Systems Biology Worldwide (www.sbw.fi) corporation and therefore linked with a wide expertise in in silico bio- and chemoinformatics, ADME/DMPK analytics, preclinical GLP in vitro and in vivo toxicology, biostatistics and clinical data management, providing you a full service portfolio as well as a comprehensive portfolio of project solutions for drug discovery. Categories of activity: Biotech company; R&D service; Other service; Drug discovery; Biomaterials; Food and feed; |
Triacle Biocomputing
Kippolankuja 7, FIN-90540 Oulu, Finland
Web site: www.triacle-bc.com
Founded: 2001 | Dr Andre H. Juffer, CEO
Phone: +358 40 740 1486
Fax: +358 8 553 1141
andre.juffer(at)oulu.fi | Production (and other) activities: Production Customized software for life science companies. Core technologies: Protein modelling, biomolecular simulation technologies, protein analysis, enzymology, protein-membrane association. Categories of activity: Biotech company; R&D; Bioinformatics; |
Turku Allergy Factory AB
| | Categories of activity: |
Turku Biomaterials Centre
| | Categories of activity: |
Turku Center for Disease Modeling
| | Categories of activity: |
Turku CRC
| | Categories of activity: |
Turku PET Centre
| | Categories of activity: |
Turku Science Park Oy / BioTurku / HealthBIO
Itäinen Pitkäkatu 4 B, FIN-20520 Turku, Finland
Web site: www.turkusciencepark.com
Founded: 1988
Turnover: EUR 7 million
Personnel: 40 | Tero Piispanen, Program Director
Phone: +358 400 781 683
Fax: +358 2 4101 830
tero.piispanen(at)turkusciencepark.com | Production (and other) activities: Turku Science Park Ltd coordinates the activity of the regional BioTurku® cluster as well as the national HealthBIO network covering the five majour Finnish regional bioclusters within the new Centre of Expertise Programme 2007-2013.
BioTurku® is the cluster of biotech actors in the Turku region including about 90 biotechnology companies, 3 universities as well as several educational and research institutes.
Turku Science Park Ltd coordinates the development of the BioTurku® cluster, offers various services for the bio community and premises for national and international life science companies – with the goal to increase entrepreneurship in the Turku region.The focus areas of BioTurku are drug discovery and development, diagnostics, biomaterials and functional foods. The four therapeutic focus areas are hormonal diseases and cancer, inflammatory and infectious diseases, diseases of the CNS and regenerative medicine including biomaterials.
The HealthBIO work programme focuses on health-related biotechnology and associated business areas http://www.healthbio.fi
Categories of activity: Biotech centre; Other service; |
UCB Pharma Oy Finland
| | Categories of activity: |
Uniq Bioresearch Oy Ltd
Kuurinniityntie 26, FI-02750 Espoo, Finland
Web site: www.uniqbioresearch.com
Founded: 1996
Personnel: 2 | Jouko Savolainen, Managing Directort
Phone: +358 40 5102608
Fax: +358 9 5864503
jouko.savolainen(at)uniqbioresearch.com Antti Äkräs, Business Advisor
Phone: +358 40 595 4621
Fax: +358 9 5864503
antti.akras(at)uniqbioresearch.com | Production (and other) activities: Production of modified/activated whey protein and whey protein fractions (ActiwheyR- proteins) for the products applications in food, health product, pharmaceutical and cosmetic industry.
Production of the products containing ActiwheyR- proteins as an active ingredient in all the product area listed above. The main product category is the microencapsulation. R&D activities: Development of the method and process for the microencapsulation of the ingredients of customers e.g. omega-oils, other lipids, liposomes, plant extracts etc. Core technologies: Technology for the modification/activation and fractionation of whey protein; patented and for licensing.
(Technology for the production of the ActiwheyR- proteins.)
Technology for the microencapsulation of sensitive ingredients by using ActiwheyR- proteins as an encapsulant; patented and for licensing. Categories of activity: Biotech company; Production; R&D; R&D service; Biomaterials; Food and feed; |
University of Kuopio
Centre for Training and Development
| | Categories of activity: |
University of Turku Clinical Research Services Turku CRST
| | Categories of activity: |
Vaccine Research Center
| | Categories of activity: |
Vactech Oy
Biokatu 8, FI-33520 Tampere, Finland
Web site: www.vactech.fi
Founded: 2001
Personnel: 8 (2009) | Raimo Harju, CEO
Phone: +358-3-4478111
Fax:
forname.surname (at) vactech.fi Olli Laitinen, CSO
Phone: +358-3-4478111
Fax:
forname.surname (at) vactech.fi | Production (and other) activities: We develop and license vaccines and novel technologies for vaccines and diagnostics. R&D activities: Primary lead:
• Preventive vaccine for Type 1 Diabetes
Other leads:
• Asthma-Allergy vaccine
• IMAVAC™ -technology based on VLP (Virus Like Particles)
• Immunomodulators
IPR:
• Type 1 Diabetes: internationally patented
• Asthma and Allergy: PCT passed
• Celiac: PCT passed
Deals:
• Diabetes vaccine licensed to Sanofi -Pasteur Core technologies: Traditional vaccines contain either killed or attenuated viruses. A more modern approach is a concept of Virus Like Particles, VLP. VLP-based vaccines have important advantages over traditional vaccines since they give stronger immunostimulation than denatured virus particles or soluble viral proteins. In addition, they are often eff ective at eliciting both T-and B-cell immune responses while traditional vaccines induce mainly B-cell responses. _ e potential of this technology is already demonstrated by the striking success of the fi rst VLP-based human vaccines targeting papillomavirus- induced cervical cancer. In addition to vaccines Vactech IMAVAC™ VLP technology opens doors to other applications such as vaccine components (adjuvant), delivery vehicles and diagnostics. Categories of activity: Biotech company; R&D; R&D service; Drug discovery; Diagnostics and devices; |
Valio Ltd
PO Box 10, FI-00039 Valio, Finland
Web site: www.valio.com
Founded: 1905
Turnover: EUR 1582 million (2004)
Personnel: 4389 (2004) | Dr Tiina Mattila-Sandholm, Senior Vice President, R&D
Phone: +358 10 381 3004
Fax: +358 10 381 3009
tiina.mattila-sandholm(at)valio.fi | Production (and other) activities: Milk production, collection, manaufacture, marketing and product development of the dairy products of Valio. Marketing of probiotic bacteria, starter cultures, animal probiotics and antibiotic tests. R&D activities: Production development of the dairy products of Valio. Nutrition research to test the probiotic bacteria and milk components used in functional foods, lactic acid bacteria. Core technologies: Low lactose products, lactose free milk, milk membrane process technology, enzyme technology, fermentation process technology. Categories of activity: Biotech company; Production; R&D; Food and feed; |
Verdera Oy
PO Box 5 (Luoteisrinne 2), FI-02271 Espoo, Finland
Web site: www.verdera.fi
Founded: 2002
Personnel: 13 (2007) | Jyrki Kyöttinen, Managing Director
Phone: +358 10 217 3715
Fax: +358 10 217 3711
jyrki.kyottinen(at)verdera.fi Heli Hynynen, Assistant
Phone: +358 10 217 3720
Fax: +358 10 217 3711
heli.hynynen(at)verdera.fi | Production (and other) activities: Developes, produces and markets biological pesticides and growth promoters used in forestry, horticulture, turf and amenity. R&D activities: Control of soil-borne as well as foliar plant diseases, process development of the production of biofungicides. Core technologies: Control of plant diseases by microorganisms, formulation techniques for microorganism. Categories of activity: Biotech company; Production; R&D; Agro; |
Verman Oy
| | Categories of activity: |
Verso Finland Oy
| | Categories of activity: |
Vetcare Ltd
Vetcare Ltd, PO Box 99, FIN-24101 Salo, Finland
Web site: www.vetcare.fi
Founded: 1992
Turnover: EUR 3 million
Personnel: 12 | Jukka Kuussaari, Managing Director
Phone: +358 2 72 72 72
Fax: +358 2 72 72 70
jukka.kuussaari(at)vetcare.fi | Production (and other) activities: Research and development, regulatory services and marketing of veterinary pharmaceuticals. R&D activities: R&D of veterinary pharmaceuticals and other animal health related products. Categories of activity: Biotech company; R&D; Drug discovery; |
Viikki Food Centre
| | Categories of activity: |
Visipoint Oy
| | Categories of activity: |
Vitabalans Oy
| | Categories of activity: |
Vivoxid Ltd
Biolinja 12, FI-20750 Turku, Finland
Web site: www.vivoxid.com
Founded: 2001
Personnel: 20 (2007) | Tomi Numminen, President, CEO
Phone: +358 (0)20 7622 266
Fax: +358 (0)20 7622 262
contact(a)vivoxid.com | Production (and other) activities: Development, production and marketing of biomaterial, medical device products. Quality system according to ISO 9001:2000 and ISO 13485:2003. R&D activities: Vivoxid’s active research program aims to create a continuous flow of new inventions and product ideas to its development portfolio. Vivoxid’s core knowhow relateds to the development of biomaterials and their interactions with the various tissues. Research projects utilize the core competence in many application areas such as medical device development, regenerative medicine, in vitro analytics etc. These projects provide the basic proof of concept, a well educated expert group behind the technology and gives the tools for the actual product development that are all prerequisites for any successful project.
Vivoxid Ltd has its roots in strong university research. The Turku University Biomaterials Research Project and Åbo Akademi Biomaterials research were established in 1986 and now involve altogether around 100 active research personnel. The research interests and main competence areas in Turku University, Åbo Akademi University have evolved around Silica titanium oxides, glasses, sol-gel materials, biodegradable polymers and their composites as well as their application in many areas of medicine and biological research. Core technologies: BonAliveTM is already registered and sold in Europe and is under registration phase in several other countries, MetAliveTM is in its clinical phase and is expected to enter the market with first indications in 2008 and FiberLiveTM is in the research and development phase with market entrance expected in 2012. Various other technology developments are at an even earlier research and development phase. Categories of activity: Biotech company; Biotech support company; Production; R&D; Other service; Supplier; Diagnostics and devices; Biomaterials; |
VTT Technical Research Centre of Finland (Biotechnology
food industry
pharmaceuticals)
| | Categories of activity: |
VWR International
Pihatörmä 1 C 1, 02240 Espoo, Finland
Web site: http://fi.vwr.com
Founded: 1985
Turnover: EUR 11,5 million (2008)
Personnel: 27 (2008) | Minna Nymark, Managing Director
Phone: +358 44 092 4030
Fax:
minna.nymark(at)fi.vwr.com Kaarlo Nuutinen, Sales Director
Phone: +358 40 0310 439
Fax:
kaarlo.nuutinen(at)fi.vwr.com | Production (and other) activities: VWR International is a global laboratory supply and distribution company with worldwide sales in excess of $3.7 billion. VWR enables the advancement of the world’s most critical research through the distribution of a highly diversified product line to most of the world’s top pharmaceutical and biotech companies, as well as industrial, educational and governmental organizations. With 150 years of industry experience, VWR offers a well-established distribution network that reaches thousands of specialized labs and facilities spanning the globe. VWR has over 6,500 associates around the world working to streamline the way researchers across North America, Europe, and Asia stock and maintain their labs. In addition, VWR further supports its customers by providing onsite services, storeroom management, product procurement, supply chain systems integration and technical services. R&D activities: - Core technologies: - Categories of activity: Biotech support company; Production; Other service; Supplier; Drug discovery; Diagnostics and devices; Biomaterials; Food and feed; Environment; Enzymes; Research reagents; |
Xemet Ltd
Myötätuulenmäki 1 B 34, 02330 Espoo
Web site: www.xemet.com
| Tomi Heiskanen, CEO
Phone: +358 400 491568
Fax: +358 9 4129090
tomi(at)xemet.com | Production (and other) activities: Mathematical modeling and simulation services and software for biological applications R&D activities: Mathematical and numerical methods for simulation Core technologies: Computer simulation Categories of activity: Biotech company; Biotech support company; R&D service; Drug discovery; Bioinformatics; Environment; |
Zeus Tech Oy
| | Categories of activity: |
Zora Biosciences Oy
FI-02150 Espoo
Web site: www.zora.fi
Founded: 2006 | Reini Hurme, Chief Executive Officer
Phone: +358 40 576 0766
Fax:
reini.hurme(at)zora.fi | Production (and other) activities: Zora provides metabolomic services to pharmaceutical companies and develops biomarkers for healthcare diagnostics. R&D activities: Zora develops innovative prognostic and diagnostic biomarkers. Zora biomarker research covers several therapy areas and promising biomarker candidates are being investigated in cardiovascular diseases, diabetes and CNS disorders. Core technologies: Metabolomic analyses, lipid biochemistry, mass spectrometry, bioinformatics Categories of activity: Biotech company; R&D; R&D service; Diagnostics and devices; Bioinformatics; |